<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Oncotarget</journal-id>
<journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id>
<journal-id journal-id-type="publisher-id">Oncotarget</journal-id>
<journal-id journal-id-type="publisher-id">ImpactJ</journal-id>
<journal-title-group>
<journal-title>Oncotarget</journal-title>
</journal-title-group>
<issn pub-type="epub">1949-2553</issn>
<publisher>
<publisher-name>Impact Journals LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29163854</article-id>
<article-id pub-id-type="pmc">5685775</article-id>
<article-id pub-id-type="publisher-id">21234</article-id>
<article-id pub-id-type="doi">10.18632/oncotarget.21234</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vallée</surname>
<given-names>Alexandre</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Yves</given-names>
</name>
<xref ref-type="aff" rid="A3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guillevin</surname>
<given-names>Rémy</given-names>
</name>
<xref ref-type="aff" rid="A4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vallée</surname>
<given-names>Jean-Noël</given-names>
</name>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="A5">
<sup>5</sup>
</xref>
</contrib>
</contrib-group>
<aff id="A1"><sup>1</sup> Experimental and Clinical Neurosciences Laboratory, INSERM U1084, University of Poitiers, Poitiers, France</aff>
<aff id="A2"><sup>2</sup> Laboratory of Mathematics and Applications (LMA), UMR CNRS 7348, University of Poitiers, Poitiers, France</aff>
<aff id="A3"><sup>3</sup> Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien (GHEF), Meaux, France</aff>
<aff id="A4"><sup>4</sup> DACTIM, UMR CNRS 7348, University of Poitiers et CHU de Poitiers, Poitiers, France</aff>
<aff id="A5"><sup>5</sup> CHU Amiens Picardie, University of Picardie Jules Verne (UPJV), Amiens, France</aff>
<author-notes>
<corresp id="cor1">
<bold>
<italic>Correspondence to:</italic>
</bold>
<italic>Alexandre Vallée,</italic>
<email>alexandre.g.vallee@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="collection">
<day>27</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>52</issue>
<fpage>90579</fpage>
<lpage>90604</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2017 Vallée et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License 3.0</ext-link> (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<abstract>
<p>Radiation therapy induces DNA damage and inflammation leading to fibrosis. Fibrosis can occur 4 to 12 months after radiation therapy. This process worsens with time and years. Radiation-induced fibrosis is characterized by fibroblasts proliferation, myofibroblast differentiation, and synthesis of collagen, proteoglycans and extracellular matrix. Myofibroblasts are non-muscle cells that can contract and relax. Myofibroblasts evolve towards irreversible retraction during fibrosis process. In this review, we discussed the interplays between transforming growth factor-β1 (TGF-β1), canonical WNT/β-catenin pathway and peroxisome proliferator-activated receptor gamma (PPAR γ) in regulating the molecular mechanisms underlying the radiation-induced fibrosis, and the potential role of PPAR γ agonists. Overexpression of TGF-β and canonical WNT/β-catenin pathway stimulate fibroblasts accumulation and myofibroblast differentiation whereas PPAR γ expression decreases due to the opposite interplay of canonical WNT/β-catenin pathway. Both TGF-β1 and canonical WNT/β-catenin pathway stimulate each other through the Smad pathway and non-Smad pathways such as phosphatidylinositol 3-kinase/serine/threonine kinase (PI3K/Akt) signaling. WNT/β-catenin pathway and PPAR γ interact in an opposite manner. PPAR γ agonists decrease β-catenin levels through activation of inhibitors of the WNT pathway such as Smad7, glycogen synthase kinase-3 (GSK-3 β) and dickkopf-related protein 1 (DKK1). PPAR γ agonists also stimulate phosphatase and tensin homolog (PTEN) expression, which decreases both TGF-β1 and PI3K/Akt pathways. PPAR γ agonists by activating Smad7 decrease Smads pathway and then TGF-β signaling leading to decrease radiation-induced fibrosis. TGF-β1 and canonical WNT/β-catenin pathway promote radiation-induced fibrosis whereas PPAR γ agonists can prevent radiation-induced fibrosis.</p>
</abstract>
<kwd-group>
<kwd>TGF-β</kwd>
<kwd>canonical WNT/β-catenin pathway</kwd>
<kwd>PPAR γ</kwd>
<kwd>radiation-induced fibrosis</kwd>
<kwd>myofibroblast</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>Patients suffering of cancer often receive an external ionizing radiation therapy in association with surgery/chemotherapy or alone. This ionizing radiation can involve damages in tumor cells but also in healthy tissue in the radiation field. Radiation therapy induces several skin changes such as inflammation, edema, dermatitis, ulceration, late radiation-induced fibrosis (RIF), and necrosis [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>]. Radiation dose, fraction size and volume treated will vary the late side effects of radiation.</p>
<p>Radiation-induced fibrosis is marked by fibroblasts proliferation, myofibroblast differentiation, and synthesis of collagen, proteoglycans and extracellular matrix. [<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R4">4</xref>]. RIF can occur 4 to 12 months after radiation therapy, and this process is worsening with time and years. Every radiation-exposed part of the body can be affects by RIF, and the type of tissue exposed will influence the clinical presentation. RIF manifestations are multiple, such as skin induration and thickening, muscle shortening and atrophy, limited joint mobility, lymphedema, mucosal fibrosis, ulceration, fistula, hollow organ stenosis, and pain [<xref ref-type="bibr" rid="R5">5</xref>] and generally impact the quality of life [<xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref>]. Fibrosis present an active retraction of the granulation tissue which is induced by contractile non-muscle cells, named myofibroblasts [<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref>]. Fibroblasts and myofibroblasts are key effectors involved in the development of fibrosis due to excessive deposition of collagen and inappropriate extracellular matrix (ECM).</p>
<p>RIF is characterized by a DNA damage [<xref ref-type="bibr" rid="R11">11</xref>–<xref ref-type="bibr" rid="R14">14</xref>] and an inflammation [<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R18">18</xref>]. Prolonged alteration of nuclear factor kappa B (NF-κB) pathway, a major effector of inflammation, leads to increase pro-fibrotic and pro-inflammatory cytokines which participate to the onset and the progression of RIF [<xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>].</p>
<p>DNA damage and inflammation stimulate transforming growth factor β1 (TGF-β1) activity, which induces fibrosis mechanism [<xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref>]. Furthermore, progression of radiation doses increases levels of TGF-β [<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R23">23</xref>].</p>
<p>TGF-β1 interacts with the canonical WNT/β-catenin pathway and peroxisome proliferator activated receptor γ (PPAR γ) which act in an opposite manner in several pathologies [<xref ref-type="bibr" rid="R24">24</xref>]. TGF-β1 stimulates myofibroblast differentiation by the activation of canonical WNT pathway and the downregulation of PPAR γ expression [<xref ref-type="bibr" rid="R25">25</xref>]. In response to TGF-β1, resident fibroblasts transdifferentiate into contractile myofibroblasts which express α -smooth muscle actin (α -SMA) and synthesize extracellular matrix proteins, particularly collagen.</p>
<p>We focus this review on the positive link between TGF-β1 and canonical WNT/β-catenin pathway and the opposite role of PPAR γ.</p>
<sec id="s1_1">
<title>Radiation-induced fibrosis (RIF)</title>
<p>Radiation-induced fibrosis (RIF) is a major late effect which contributes to patient morbidity and occur in the skin, and subcutaneous tissue, lungs, gastrointestinal as well as any other organs in the treatment field. The mechanisms linking radiation to tissue sclerosis, fibrosis and atrophy are complex. In both tumors and normal tissues, radiation causes the induction of apoptosis or clonogenic cell death through free radical-mediated DNA damage [<xref ref-type="bibr" rid="R26">26</xref>]. In normal tissues, radiation toxicity induces changes in cell functions and causes activation of coagulation system, inflammation, epithelial regeneration, and tissue remodeling, which are precipitated by several signaling such as cytokines, chemokines and growth factors [<xref ref-type="bibr" rid="R27">27</xref>].</p>
<sec id="s1_1_1">
<title>Etiology of RIF</title>
<p>Several factors can increase the risk of RIF. Total dose of radiotherapy and dose per fraction, volume of tissue treated, and time of treatment delivery are considered as primary factors. Increased levels of radiation dose, hypofractionation and increased field size are directly correlated with degree of RIF [<xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R32">32</xref>]. Patients with certain diseases are more susceptible to develop severe RIF, such as systemic scleroderma, systemic lupus erythematosus (SLE), or Marfan syndrome [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R34">34</xref>]. Genetics factors have also a role in the predisposition to RIF [<xref ref-type="bibr" rid="R35">35</xref>, <xref ref-type="bibr" rid="R36">36</xref>]. Single-nucleotide polymorphisms have been observed in genes encoding proteins such as TGF-β1, and superoxide dismutase 2 (SOD2) [<xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>]. Additional genes like <italic>IL18</italic> (interleukin 18), <italic>MMP12</italic> (matrix metalloproteinase 12), <italic>PER3</italic> (period circadian protein homolog 3 protein), <italic>LTF</italic> (lactoferrin) stimulate the degradation of post-radiation ECM [<xref ref-type="bibr" rid="R39">39</xref>]. Several DNA modifications have been associated with RIF, like epigenetic modifications to DNA and histones [<xref ref-type="bibr" rid="R40">40</xref>]. Mitochondrial DNA damage enhance the removal of reactive oxygen species (ROS) [<xref ref-type="bibr" rid="R41">41</xref>].</p>
</sec>
<sec id="s1_1_2">
<title>Clinical presentation of RIF</title>
<p>RIF usually occurs 4 to12 months after radiation therapy and can progress over many years. The type of tissue exposed to irradiation is responsible for the clinical presentation. In general, RIF can manifest as skin induration and thickening, muscle shortening and atrophy, limited joint mobility, lymphedema, mucosal fibrosis, ulceration, fistula, hollow organ stenosis, and pain [<xref ref-type="bibr" rid="R5">5</xref>]. Other manifestations more regionally and specific include trismus, xerostomia, decreased vocal quality, osteoradionecrosis, dysphagia, and aspiration in patients with head and neck malignancy [<xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R47">47</xref>]; cervical plexopathy, brachial plexopathy, interstitial fibrosis, dyspnea, and oxygen requirement in patients with breast or lung malignancy [<xref ref-type="bibr" rid="R48">48</xref>, <xref ref-type="bibr" rid="R49">49</xref>]; and urinary urgency, increased urinary frequency, diarrhea, loss of reproductive function, and dyspareunia in patients with abdominopelvic malignancy [<xref ref-type="bibr" rid="R50">50</xref>–<xref ref-type="bibr" rid="R52">52</xref>]. Currently, there is no uniform consensus to objectively quantify the degree of fibrosis in RIF [<xref ref-type="bibr" rid="R53">53</xref>].</p>
</sec>
<sec id="s1_1_3">
<title>Pathogenesis of RIF</title>
<p>Three histopathological phases of RIF are described. The prefibrotic phase shows chronic inflammation in which endothelial cells have a major role. The organized fibrosis phase contains a high density of myofibroblasts in an unorganized matrix adjacent to poorly cellularized fibrotic areas of senescent fibrocytes in a dense sclerotic matrix. The third phase named late fibroatrophic phase shows retractile fibrosis and gradual loss of parenchymal cells [<xref ref-type="bibr" rid="R54">54</xref>].</p>
<p>RIF is initially characterized by an injury which incites an acute response leading to inflammation, followed by the accumulation of fibroblasts, differentiation into myofibroblasts, and activation of extracellular matrix proteins like collagen [<xref ref-type="bibr" rid="R22">22</xref>]. Radiation induces direct DNA damages and the apparition of reactive oxygen species (ROS) [<xref ref-type="bibr" rid="R55">55</xref>] resulting in oxidative stress [<xref ref-type="bibr" rid="R56">56</xref>]. ROS involves interactions of ionizing radiation with water molecules and then the formation of free radicals such as superoxide, hydrogen peroxide and hydroxyl radical [<xref ref-type="bibr" rid="R57">57</xref>]. Hydroxyl radical production is responsible for the major part of damages [<xref ref-type="bibr" rid="R58">58</xref>, <xref ref-type="bibr" rid="R59">59</xref>]. ROS generation and free radicals lead to a deterioration of cellular compounds such as DNA, RNA, proteins, lipids and membranes [<xref ref-type="bibr" rid="R58">58</xref>–<xref ref-type="bibr" rid="R60">60</xref>]. Superoxide dismutase, glutathione peroxidase and catalase control free radical damages [<xref ref-type="bibr" rid="R61">61</xref>]. Several studies have shown that a depletion of these enzymes stimulate oxidative stress [<xref ref-type="bibr" rid="R62">62</xref>–<xref ref-type="bibr" rid="R64">64</xref>]. During RT, injured cells lead to the release of chemoattractant molecules which can stimulate inflammation [<xref ref-type="bibr" rid="R55">55</xref>, <xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref>]. Furthermore, release of inflammatory cytokines and chemokines is exacerbated by thrombosis and ischemia [<xref ref-type="bibr" rid="R67">67</xref>, <xref ref-type="bibr" rid="R68">68</xref>].</p>
<p>The first inflammatory cells which arrived at injured sites are neutrophils [<xref ref-type="bibr" rid="R69">69</xref>]. Neutrophils encounter fibronectin and collagen fragments and then lead to the release of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukin 1 (IL-1), and interleukin 6 (IL-6) for the initiation of ROS and local inflammation [<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R70">70</xref>–<xref ref-type="bibr" rid="R74">74</xref>]. Theses inflammatory cytokines are correlated with high collagen deposition and with the onset of RIF [<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R75">75</xref>–<xref ref-type="bibr" rid="R78">78</xref>]. Monocytes and lymphocytes then interact with injured cells and stimulate the differentiation of monocytes into two subset of macrophages (M1 and M2) [<xref ref-type="bibr" rid="R79">79</xref>–<xref ref-type="bibr" rid="R81">81</xref>]. Subset M2 of macrophages secrete platelet-derived growth factor (PDGF) which stimulate the migration of fibroblast into injured tissue and the promotion of neo-angiogenesis [<xref ref-type="bibr" rid="R82">82</xref>]. Subset M2 of macrophages also secrete TGF-β, which is the main effector of Rif [<xref ref-type="bibr" rid="R83">83</xref>]. PDGF and TGF-β cascades are increased in lung tissues after RT [<xref ref-type="bibr" rid="R84">84</xref>–<xref ref-type="bibr" rid="R87">87</xref>].</p>
<p>TGF-β is responsible for the production of fibroblasts from bone marrow progenitors [<xref ref-type="bibr" rid="R88">88</xref>, <xref ref-type="bibr" rid="R89">89</xref>] and for the differentiation of fibroblast into myofibroblasts [<xref ref-type="bibr" rid="R14">14</xref>]. The differentiation of fibroblasts results in activation of the expression of α-smooth muscle actin (α-SMA) which is responsible for the transformation of proto-myofibroblasts into matured myofibroblasts [<xref ref-type="bibr" rid="R90">90</xref>]. Fibrocytes (bone marrow-derived progenitor cells) and epithelial cells during epithelial-mesenchymal transition (EMT) can also be at the origin of myofibroblasts [<xref ref-type="bibr" rid="R91">91</xref>]. Activated myofibroblasts, by overexpression of TGF-β, secrete too much collagen, fibronectin and proteoglycans [<xref ref-type="bibr" rid="R92">92</xref>]. This phenomenon is responsible for stiffness and thickening of tissues under RT [<xref ref-type="bibr" rid="R68">68</xref>, <xref ref-type="bibr" rid="R93">93</xref>]. In addition, TGF-β stimulates inhibitors of matrix metalloproteinases (MMP) and then decreases the activity of MMP-2 and MMP-9, which participates to the aggravation of excessive ECM deposition [<xref ref-type="bibr" rid="R94">94</xref>]. TGF-β stimulates ECM production and collagen architecture alterations [<xref ref-type="bibr" rid="R95">95</xref>, <xref ref-type="bibr" rid="R96">96</xref>]. Excessive accumulation of collagen reduces the vascularization with time [<xref ref-type="bibr" rid="R68">68</xref>], although basic fibroblast growth factor (bFGF) is activated by myofibroblasts and participates for endothelial cell proliferation and neoangiogenesis [<xref ref-type="bibr" rid="R97">97</xref>]. Loss of cell functions, tissue atrophy, and then necrosis are induced by damages and gradual ischemia suffered by radiation-induced fibrosis [<xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R98">98</xref>–<xref ref-type="bibr" rid="R100">100</xref>]. However, the apparition of early fibrosis is not correlated with the development of lasted effects of RIF [<xref ref-type="bibr" rid="R101">101</xref>–<xref ref-type="bibr" rid="R103">103</xref>].</p>
</sec>
</sec>
<sec id="s1_2">
<title>TGF-β and radiation therapy (cf. Figure <xref ref-type="fig" rid="F1">1</xref>)</title>
<p>Transforming growth factor β (TGF-β) is made of three similar proteins: TGF-β1, TGF-β2 and TGF-β3. TGF-β receptor 1 and TGF-β receptor 2 are transmembrane proteins. TGF-β1 binds TGF-βR2 which recruits TGF-βR1. TGF-β1 is secreted and then deposited into ECM and considered as a large latent complex. ECM is a main reservoir of cytokines [<xref ref-type="bibr" rid="R104">104</xref>]. TGF-β1 stimulates the Smad pathway and non-Smad pathways such as phosphatidylinositol 3-kinase/serine/threonine kinase (protein kinase B) (PI3K/Akt), Rho, and MAPK. Radiation-induced fibrosis is characterized by an upregulation of TGF-β1 [<xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R84">84</xref>, <xref ref-type="bibr" rid="R105">105</xref>, <xref ref-type="bibr" rid="R106">106</xref>].</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Processes for the development and progression of radiation-induced fibrosis</title>
</caption>
<graphic xlink:href="oncotarget-08-90579-g001"></graphic>
</fig>
<p>TGF-β is responsible for the control of many functions, like breakdown of connective tissue, inhibition of epithelial cell proliferation and synthesis of extracellular matrix proteins (collagen and MMPs) [<xref ref-type="bibr" rid="R106">106</xref>].</p>
<p>Several studies have shown a weakly activation of TGF-β1 on day 1 after irradiation whereas its activation is strongly on day 14 after irradiation [<xref ref-type="bibr" rid="R106">106</xref>]. Thus, the irradiation-induced activation of TGF-β1 is rapid [<xref ref-type="bibr" rid="R107">107</xref>–<xref ref-type="bibr" rid="R110">110</xref>]. EMT is initiated by a prolonged irradiation exposure to TGF-β1 and this activates several transcriptional signaling pathways [<xref ref-type="bibr" rid="R111">111</xref>–<xref ref-type="bibr" rid="R113">113</xref>]. Radiation increases fibroblast differentiation-induced alpha-smooth muscle actin (α-SMA) activation [<xref ref-type="bibr" rid="R114">114</xref>]. Myofibroblast activation releases α-SMA or myofibroblasts activate the release α-SMA and α-SMA confers to myofibroblasts a strong contractile property [<xref ref-type="bibr" rid="R115">115</xref>, <xref ref-type="bibr" rid="R116">116</xref>]. The interplay between TGF-β and several molecules, like extracellular signal-related kinase (EK), mitogen-activated protein kinase (MAPK), WNT, and PI3K, can explain the extent and the reversibility of EMT) [<xref ref-type="bibr" rid="R113">113</xref>].</p>
<p>A close relationship is observed between irradiation dose and liver cell viability [<xref ref-type="bibr" rid="R117">117</xref>]. Indeed, ionizing irradiation induces a progressive change in mRNA levels which gradually increase with time [<xref ref-type="bibr" rid="R118">118</xref>, <xref ref-type="bibr" rid="R119">119</xref>]. Evolution of α-SMA in liver fibrosis induction suggests a time-dependent effect of irradiation [<xref ref-type="bibr" rid="R120">120</xref>, <xref ref-type="bibr" rid="R121">121</xref>]. TGF-β1 expression gradually increases in a dose-dependent manner and peaking 4 weeks after irradiation [<xref ref-type="bibr" rid="R122">122</xref>].</p>
</sec>
<sec id="s1_3">
<title>The contractile non-muscle cells: myofibroblasts</title>
<p>Myofibroblasts contain actin filaments bundles with α-SMA. α-SMA represents peripheral focal adhesions and gap junctions for the connection between myofibroblats and granulation tissues [<xref ref-type="bibr" rid="R123">123</xref>]. Fibroblasts become protomyofibroblats after this interaction.</p>
<p>Protomyofibroblasts synthetize ECM, collagen, fibronectin which are essential for differentiation [<xref ref-type="bibr" rid="R124">124</xref>]. Then, protomyofibroblasts differentiate into myofibroblasts containing α-SMA. α-SMA is responsible for the retractile role of myofibroblasts [<xref ref-type="bibr" rid="R25">25</xref>]. Apoptosis is the final stage of myofibroblasts [<xref ref-type="bibr" rid="R125">125</xref>].</p>
<p>Mesenchymal stem cells (MSC) and fibroblasts are at the precursors of myofibroblasts, and these cells are found in normal tissues, like lung alveolar septa, uterine submucosa, lymph nodes, spleen, adrenal capsule, periodontal ligament, intestinal crypts and bone marrow stroma [<xref ref-type="bibr" rid="R115">115</xref>, <xref ref-type="bibr" rid="R125">125</xref>].</p>
<p>Several diseases show myofibroblasts such as idiopathic pulmonary fibrosis and epithelial cancers [<xref ref-type="bibr" rid="R116">116</xref>]. In hypertrophic scar, myofibroblasts can persist after wound closure [<xref ref-type="bibr" rid="R126">126</xref>]. Precursors of myofibroblasts can be smooth muscle cells in coronary atheromatous plaque [<xref ref-type="bibr" rid="R127">127</xref>], perisinusoidal cells in liver [<xref ref-type="bibr" rid="R128">128</xref>], keratocytes in eyes [<xref ref-type="bibr" rid="R115">115</xref>], pericytes in kidneys [<xref ref-type="bibr" rid="R129">129</xref>], and bone marrow-derived fibrocytes [<xref ref-type="bibr" rid="R130">130</xref>]. Myofibroblasts are also observed in several pathological tissues like cancers (mammary carcinoma, epithelial cells in cancerous mammary glands), and fibrotic lesions [<xref ref-type="bibr" rid="R131">131</xref>].</p>
<p>Moreover, non-fibroblastic cell lineages [<xref ref-type="bibr" rid="R132">132</xref>–<xref ref-type="bibr" rid="R134">134</xref>] can differentiate into myofibroblasts through EMT process [<xref ref-type="bibr" rid="R135">135</xref>]. Differentiation of fibroblasts into myofibroblasts needs the participation of physical and chemical factors with increased stiffness of tissues [<xref ref-type="bibr" rid="R90">90</xref>, <xref ref-type="bibr" rid="R136">136</xref>] and association of TGF-β1 with extra domain A (EDA) fibronectin [<xref ref-type="bibr" rid="R124">124</xref>, <xref ref-type="bibr" rid="R137">137</xref>]. α-SMA increases contractile property of myofibroblasts and is synthesized through TGF-β1 activation [<xref ref-type="bibr" rid="R138">138</xref>]. The transmission of force generated by α-SMA and the molecular motor myosin are allowed by ECM through focal adhesions containing transmembrane integrins [<xref ref-type="bibr" rid="R139">139</xref>]. TGF-β1 is activated through an integrin-dependent process in ECM [<xref ref-type="bibr" rid="R126">126</xref>].</p>
<p>Myofibroblasts are contractile non-muscle cells, characterized by the type IIA non-muscle myosin (NMIIA) [<xref ref-type="bibr" rid="R140">140</xref>]. NMII are responsible for cell polarity, cell migration and cell-cell adhesion. NMIIA are highly observed in myofibroblasts of human placental stem villi [<xref ref-type="bibr" rid="R141">141</xref>, <xref ref-type="bibr" rid="R142">142</xref>]. NMIIA is characterized by three pairs of chains, two heavy chains of 230 kDa, two 20 kDa regulatory light chains (RLCs) which stimulate the NMII activity and two 17 kDa essential light chains (ELCs) which stabilize the heavy chain structure. Calcium-calmodulin-myosin light chain kinase (MLCK) and Rho/ROCK/myosin light chain phosphatase increases NMII activity [<xref ref-type="bibr" rid="R90">90</xref>, <xref ref-type="bibr" rid="R143">143</xref>, <xref ref-type="bibr" rid="R144">144</xref>].</p>
<p>Myosin filaments link actin filaments in thick bundles like as stress fibers. NMMIIA molecules assemble into bipolar filaments. A title of the head enables a conformational change that moves actin filaments in an anti-parallel manner. The cross-bridge actin-myosin cycle of NMIIA is overall like smooth and striated muscle myosin. An ATP molecule binds the NMIIA-ATPase site on the myosin head. This allows the dissociation of actin from the NMIIA head. ATP is then hydrolyzed and subsequently, NMIIA binds to actin. Then, the power stoke occurs with a tilt of the NMIIA head, which generates a CB single force and a displacement of few nanometers. ADP is then released from the acto-NMIIA complex. A new ATP molecule dissociates actin from myosin head, and a novel CB cycle begins.</p>
<p>However, the major feature of NMIIA is its extreme slowness, with dramatic slow of its kinetics of contractile [<xref ref-type="bibr" rid="R145">145</xref>, <xref ref-type="bibr" rid="R146">146</xref>]. The cross-bridge actin-myosin detachment constant, attachment constant, catalytic constant are widely low compared with striated or smooth muscles. Nevertheless, the cross-brigde actin-myosin of NMIIA single force is same order of magnitude compared with muscle myosin II (MII). Thermodynamic force, thermodynamic flow and thermodynamic entropy production rate are rarely low [<xref ref-type="bibr" rid="R147">147</xref>]. This explains why this stationary contractile system operates near-equilibrium. The low isometric tension observed in placental stem villi [<xref ref-type="bibr" rid="R141">141</xref>, <xref ref-type="bibr" rid="R148">148</xref>] can be surely explained by the low placental myosin content [<xref ref-type="bibr" rid="R149">149</xref>, <xref ref-type="bibr" rid="R150">150</xref>]. The extremely slow shortening velocity can be accounted for by the very low placental myosin ATPase activity which has an essential role for the association/dissociation of actin from the NMIIA head [<xref ref-type="bibr" rid="R145">145</xref>, <xref ref-type="bibr" rid="R149">149</xref>]. In placental stem villi, a low isometric tension has been reported [<xref ref-type="bibr" rid="R147">147</xref>]. This can be explained by the low placental myosin content and the low placental myosin ATPase activity [<xref ref-type="bibr" rid="R148">148</xref>]. The acto-myosin apparatus functions as in smooth muscles in myofibroblasts of human placenta. In experimental bath, addition of KCl or electrical field induce the contraction phase. 2,3-butanedione monoxime, or isosorbide dinitrate, two inhibitors of NMII, can induce the relaxation phase [<xref ref-type="bibr" rid="R146">146</xref>]. Changes in the volume of the intervillons chamber can alter the length of the placental stem villi. Contraction of myofibroblasts induces a modulation of the distal resistance of the umbilical artery and then a modulation of the umbilical blood flow, due to the Starling phenomenon. In fibrotic processes, myofibroblasts generate rather a phenomenon of contraction-retraction lasting without relaxation and the pathological tissue undergoes an irreversible retraction, evolving towards fibrosis favored by the synthesis of collagen.</p>
</sec>
<sec id="s1_4">
<title>Canonical WNT/β-catenin pathway</title>
<p>Wingless and integration site (named WNT) pathway is a cascade of numerous signaling which are involved in development, metabolism, growth cellular, and maintain of stem cells [<xref ref-type="bibr" rid="R151">151</xref>]. WNT pathway is formed by secreted lipid-modified glycoproteins [<xref ref-type="bibr" rid="R152">152</xref>]. Deregulation of the canonical WNT pathway is observed in several pathologies [<xref ref-type="bibr" rid="R24">24</xref>].</p>
<p>WNT extracellular ligands bind Frizzled (FZD) receptors, low density lipoprotein receptor-related protein 5 and 6 (LRP 5/6) and disheveled (DSH), which lead to stimulate β-catenin accumulation and then the nuclear β-catenin translocation for the bind to T-cell factor/lymphoid enhancer factor (TCF/LEF) [<xref ref-type="bibr" rid="R153">153</xref>]. TCF/LEF related to nuclear β-catenin activates numerous target genes such as c-Myc, cyclin D1 [<xref ref-type="bibr" rid="R154">154</xref>].</p>
<p>Downregulation of the WNT pathway is characterized by the absence of binding between WNT extracellular ligands and the complex FZD/LRP 5/6. Thus, adenomatous polyposis coli (APC), AXIN and glycogen synthase kinase-3 (GSK-3β) form the β-catenin destruction complex and mediate degradation of β-catenin in the proteasome [<xref ref-type="bibr" rid="R155">155</xref>]. GSK-3β inhibits β-catenin accumulation and its nuclear translocation [<xref ref-type="bibr" rid="R155">155</xref>, <xref ref-type="bibr" rid="R156">156</xref>].</p>
<p>WNT/β-catenin pathway is increased in fibroblasts in response to radiation during skin fibrogenesis [<xref ref-type="bibr" rid="R157">157</xref>]. WNT ligands are activated after irradiation and promote survival in head and neck cancers [<xref ref-type="bibr" rid="R158">158</xref>, <xref ref-type="bibr" rid="R159">159</xref>]. Radiation stimulates ERK pathway through a reactive oxygen species (ROS) generation and inactivates GSK-3β [<xref ref-type="bibr" rid="R114">114</xref>]. Irradiation inhibits GSK-3β activity in mesenchymal cells [<xref ref-type="bibr" rid="R160">160</xref>] and increases WNT genes expression in fibroblasts [<xref ref-type="bibr" rid="R161">161</xref>]. Moreover, WNT/β-catenin pathway is overexpressed in liver, skin, lung, kidney, and heart presenting fibrosis [<xref ref-type="bibr" rid="R162">162</xref>–<xref ref-type="bibr" rid="R167">167</xref>].</p>
<p>Phosphatidylinositol 3-kinase/serine/threonine kinase (protein kinase B)/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is present in cell growth, proliferation, protein synthesis and energetic metabolism [<xref ref-type="bibr" rid="R168">168</xref>–<xref ref-type="bibr" rid="R171">171</xref>]. WNT/β-catenin pathway is considered as an upstream activator of PI3K/Akt/mTOR pathway [<xref ref-type="bibr" rid="R172">172</xref>] through the inhibition of GSK-3β [<xref ref-type="bibr" rid="R173">173</xref>]. In addition, diminution of bet-catenin signaling decreases the expression of PI3K/Akt/mTOR pathway [<xref ref-type="bibr" rid="R174">174</xref>, <xref ref-type="bibr" rid="R175">175</xref>]. Moreover, in adipocyte differentiation, activated PI3K/Akt pathway inhibits GSK-3β [<xref ref-type="bibr" rid="R176">176</xref>, <xref ref-type="bibr" rid="R177">177</xref>]. WNT/β-catenin pathway and PI3K/Akt/mTOR pathway mediate each other.</p>
</sec>
<sec id="s1_5">
<title>Inflammation and canonical WNT/β-catenin pathway</title>
<p>NF-κB signaling is a main effector of inflammation [<xref ref-type="bibr" rid="R178">178</xref>–<xref ref-type="bibr" rid="R180">180</xref>], its deregulation is implicated in numerous inflammatory processes [<xref ref-type="bibr" rid="R179">179</xref>–<xref ref-type="bibr" rid="R181">181</xref>]. Several studies have shown an interplay between canonical WNT/β-catenin pathway and NF-κB signaling [<xref ref-type="bibr" rid="R182">182</xref>]. Inflammation and immune response are modulated by this interaction between WNT/β-catenin pathway and NF-κB [<xref ref-type="bibr" rid="R182">182</xref>–<xref ref-type="bibr" rid="R185">185</xref>].</p>
<p>Overexpression of WNT/β-catenin pathway increases the NF-κB-mediated anti-apoptotic action [<xref ref-type="bibr" rid="R186">186</xref>, <xref ref-type="bibr" rid="R187">187</xref>], and activates inflammatory processes through the stimulation of β-catenin targets genes [<xref ref-type="bibr" rid="R188">188</xref>, <xref ref-type="bibr" rid="R189">189</xref>]. Activated β-catenin/TCF4 stimulates the NF-κB activity in vascular smooth muscle cells [<xref ref-type="bibr" rid="R190">190</xref>] and in colorectal cancer cells [<xref ref-type="bibr" rid="R191">191</xref>]. Activated WNT pathway in THP-1 cells induces release of inflammatory cytokines [<xref ref-type="bibr" rid="R192">192</xref>]. Nuclear activation of β-catenin associated with p50 and TNF-α, stimulates C-reactive protein (CRP) expression in 293T and HepG2 cells [<xref ref-type="bibr" rid="R193">193</xref>]. Nuclear β-catenin coupled with the TCF/LEF complex activates NF-κB target genes, such as CRP and matrix metalloproteinase 13 (MMP-13) in chondrocytes [<xref ref-type="bibr" rid="R194">194</xref>, <xref ref-type="bibr" rid="R195">195</xref>], and then induces their genes transcription [<xref ref-type="bibr" rid="R193">193</xref>, <xref ref-type="bibr" rid="R194">194</xref>]. In breast cancer, β-catenin/TCF and NF-κB signaling activate each other in a synergistic manner [<xref ref-type="bibr" rid="R196">196</xref>]. WNT/β-catenin pathway inhibits prolyl-hydroxylase and then activates NF-κB signaling [<xref ref-type="bibr" rid="R197">197</xref>, <xref ref-type="bibr" rid="R198">198</xref>]. GSK3-β upregulation also decreases NF-κB signaling [<xref ref-type="bibr" rid="R199">199</xref>, <xref ref-type="bibr" rid="R200">200</xref>].</p>
<p>Moreover, the NF-κB signaling activates canonical WNT/β-catenin pathway [<xref ref-type="bibr" rid="R201">201</xref>]. NF-κB activation stimulates the expression of the TCF/LEF complex and provides an indirect positive control of WNT/β-catenin pathway [<xref ref-type="bibr" rid="R202">202</xref>]. In human adipose tissue and bone marrow stroma cells, NF-κB decreases the expression of LZTS2 which inhibits β-catenin nuclear translocation and transcriptional activity [<xref ref-type="bibr" rid="R203">203</xref>, <xref ref-type="bibr" rid="R204">204</xref>]. Stimulation of IKKB kinase (IKK) α, an activator of NF-κB, leads to cytosolic accumulation of β-catenin and then activates WNT/β-catenin pathway targets genes [<xref ref-type="bibr" rid="R201">201</xref>, <xref ref-type="bibr" rid="R205">205</xref>]. Overexpression of interleukin 1 β (IL-1β) in mouse chondrocytes leads to a positive direct binding between NF-κB and LEF to induce β-catenin/LEF transcription [<xref ref-type="bibr" rid="R202">202</xref>]. NF-κB-induced TNF-α macrophages stimulates β-catenin cytosolic accumulation [<xref ref-type="bibr" rid="R206">206</xref>].</p>
<p>Ionizing radiation activates NF-κB which contributes to cell sensitivity to radiation [<xref ref-type="bibr" rid="R207">207</xref>]. NF-κB is activated in endothelial cells after irradiation and is necessary for radiation-induced IL-6 release [<xref ref-type="bibr" rid="R208">208</xref>]. Inflammation, through the activation of NF-κB, promotes the production of collagen and the release of inflammatory chemokines in the development of liver fibrosis [<xref ref-type="bibr" rid="R209">209</xref>]. NF-κB expression is stimulated by the activation of Akt pathway observed in RIF [<xref ref-type="bibr" rid="R210">210</xref>]. In fibrosis, CCN4, a WNT-inducible signaling pathway protein-1 (WISP1) is increased and participates to the fibroblast proliferation and ECM expression [<xref ref-type="bibr" rid="R211">211</xref>, <xref ref-type="bibr" rid="R212">212</xref>]. CCN4 overexpression induces morphological transformation in skin fibrosis [<xref ref-type="bibr" rid="R213">213</xref>]. CCl4mAb, a specific inhibitor of CCN4, reduces NF-κB activity and then decreases the expression of pro-fibrotic factors, such as TGF-β1, in hepatic fibrosis [<xref ref-type="bibr" rid="R214">214</xref>].</p>
</sec>
<sec id="s1_6">
<title>Interactions between TGF-β1 and canonical WNT/β-catenin pathway (cf. Figure <xref ref-type="fig" rid="F2">2</xref>)</title>
<p>The canonical Smad pathway activates intracellular TGF-β1 signaling in activated myofibroblasts. TGF-β1 binds TGF-βR2 and then interacts with TGF-βR1 to form a heterotetramer for the phosphorylation of Smad2 and Smad3 which binds Smad4. The complex formed translocates to the nucleus for the activation of Smad binding element (SBE) DNA sequences and for recruit coactivators like histone acetyltransferase p300 [<xref ref-type="bibr" rid="R215">215</xref>]. Canonical WNT ligands, such as WNT3a, increase TGF-β1 through a Smad2 activation in a β-catenin-dependent manner and lead to myofibroblasts differentiation [<xref ref-type="bibr" rid="R216">216</xref>]. A non-Smad pathway is also observed and represented by MAPK, TGF-β activated kinase (TAK1), JNK, or PI3K/Akt [<xref ref-type="bibr" rid="R133">133</xref>, <xref ref-type="bibr" rid="R217">217</xref>]. Phosphatase and tensin homolog (PTEN) is an inhibitor of PI3K/Akt pathway [<xref ref-type="bibr" rid="R218">218</xref>]. PTEN inhibits myofibroblasts differentiation, and the expression of collagen and α-SMA [<xref ref-type="bibr" rid="R219">219</xref>].</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<title>Interactions between TGF-β1, canonical WNT/β-catenin pathway, and YAP/TAZ signaling</title>
<p>In the absence of WNT ligands, Smad7 associates with β-catenin and Smurf2 to degrade β-catenin. Smad7 also binds phosphorylated YAP and Smurf to form a high affinity complex for TGF-β type 1 receptor to decrease TGF-β signaling expression. In the absence of WNT ligands, phosphorylated YAP and TAZ are associated with the β-catenin destruction complex. Phosphorylated YAP is also associated with β-catenin to inhibit its nuclear translocation and promote its degradation. Upon WNT stimulation, the beta-catenin destruction complex is inhibited and then beta-catenin accumulates in the cytosol and translocates to the nucleus. TAZ inhibits the phosphorylation of DSH and dissociates it from the β-catenin destruction complex. The destruction complex is inhibited because YAP and TAZ dissociate from the complex. β-catenin accumulates in the cytosol and then translocates to the nucleus for activating WNT targets. Upon TGF-β stimulation, Axin promotes the tail-phosphorylation of Smad2/3. Axin also forms a complex with Arkadia and Smad7 for enhancing TGF-β signaling. The activated Smad complex associates with TAZ and YAP and then translocates to the nucleus for activating Smad targets.</p>
</caption>
<graphic xlink:href="oncotarget-08-90579-g002"></graphic>
</fig>
<p>Fibroblasts stimulation with activated WNT3a enhances the expression of TGF-β and then the phosphorylation of the MH2 domain of Smad2 [<xref ref-type="bibr" rid="R216">216</xref>]. Conversely, the absence of WNT ligands decreases the expression of TGF-β and then attenuates the fibrotic response [<xref ref-type="bibr" rid="R220">220</xref>].</p>
<p>Without tail-phosphorylation by the TGF-β type I receptor, Smad2/3 cannot interact with Smad4 and then cannot engaged the DNA. Smads inactivated are phosphorylated by activated GSK-3β and then degraded [<xref ref-type="bibr" rid="R221">221</xref>]. Moreover, activation of TGF-β also enhances WNT pathway stimulation through the inhibition of dickkopf-related protein 1 (DKK1) [<xref ref-type="bibr" rid="R222">222</xref>].</p>
<p>Upon TGF-β and WNT stimulation, Axin facilitates the binding of Smad2/3 with TGF-β type 1 receptor and then activates Smad2/3 [<xref ref-type="bibr" rid="R223">223</xref>]. Moreover, upon WNT ligands activation, Axin forms a complex with Smad7 and the E3 ubiquitin ligase Arkadia to promote the degradation of Smad7 [<xref ref-type="bibr" rid="R224">224</xref>].</p>
<p>Smad7 is an inhibitor of Smad pathway [<xref ref-type="bibr" rid="R225">225</xref>]. Activated Smad7 binds YAP (yes-associated protein 1) and Smurf to increase affinity for TGF-β type 1 receptor, and then decreases TGF-β signaling [<xref ref-type="bibr" rid="R226">226</xref>]. Activated Smad7 also recruits Smurf 2 to induce ubiquitination and degradation of β-catenin [<xref ref-type="bibr" rid="R227">227</xref>].</p>
<p>Myofibroblast activation and fibrosis induction have been recently translated by the mechanical properties of YAP and TAZ. YAP and TAZ (transcriptional coactivator with PDZ-binding motif) elevated levels are observed in fibrosis [<xref ref-type="bibr" rid="R228">228</xref>]. YAP and TAZ knockdown in lung and liver fibroblasts cultured reduces the levels of protein associated with myofibroblast differentiation, such as pro-collagen and α-SMA [<xref ref-type="bibr" rid="R229">229</xref>]. During fibrosis, F-actin polymerization inactivates the Hippo core kinase complex leading to the dephosphorylation of YAP and TAZ [<xref ref-type="bibr" rid="R230">230</xref>].</p>
<p>Stimulation by WNT3a inhibits the destruction complex because YAP/TAZ dissociates from the β-catenin destruction complex and then allowed β-catenin nuclear translocation. TAZ binds DSH and dephosphorylates it upon stimulation with WNT3a to dissociate DSH from the destruction complex [<xref ref-type="bibr" rid="R231">231</xref>]. Indeed, in the absence of WNT ligands, phosphorylated YAP and TAZ bind β-catenin with activated GSK-3β and Axin to degraded β-catenin in the proteasome [<xref ref-type="bibr" rid="R232">232</xref>]. In fibrosis, activated Smad2/3-Smad4 complex is associated with YAP and TAZ for its translocation to the nucleus [<xref ref-type="bibr" rid="R233">233</xref>]. A crosstalk of several components of the TGF-β, WNT, and YAP/TAZ signaling is playing in the tuning of nucleocytoplasmic shuttling of fibrosis [<xref ref-type="bibr" rid="R230">230</xref>].</p>
</sec>
<sec id="s1_7">
<title>PPAR γ</title>
<p>Peroxisome proliferator receptor γ (PPAR γ) is a ligand activated transcriptional factor which forms a heterodimer with retinoid X receptor (RXR) to activate specific peroxisome response elements (PPRE) [<xref ref-type="bibr" rid="R234">234</xref>]. PPAR γ expression is involved in several mechanisms such as glucose and lipid metabolism, immune response, and inflammation [<xref ref-type="bibr" rid="R235">235</xref>, <xref ref-type="bibr" rid="R236">236</xref>]. PPAR γ decreases NF-κB activity and then represses inflammation [<xref ref-type="bibr" rid="R237">237</xref>]. PPAR γ is expressed in several cells, such as adipocytes, muscle cells, brain cells, immune cells and in fibroblasts [<xref ref-type="bibr" rid="R238">238</xref>].</p>
<p>15d-prostaglandin J2 (15d-PGJ2), lysophosphatidic acid, and nitrolinoleic acid are natural activators of PPAR γ [<xref ref-type="bibr" rid="R239">239</xref>], whereas thiazolidinediones (TZDs) and oleanic acid derivatives such as triterpenoids (2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid (CDDO)) are synthetic activators of PPAR γ. PPAR γ expression mediates the functions of many signaling such as connective tissue regulation, mesenchymal cell activation, differentiation and cell survival creating a link between metabolism and fibrogenesis [<xref ref-type="bibr" rid="R134">134</xref>].</p>
<p>Numerous inflammatory cytokines, chemokines, or intracellular signaling decrease PPAR γ expression such as TFG-β1, canonical WNT/β-catenin pathway, TNF-α, interleukin (IL)-1, IL-13, Connective Tissue Growth Factor (CTGF), leptin, and lysophosphatidic acid (LPA) [<xref ref-type="bibr" rid="R240">240</xref>–<xref ref-type="bibr" rid="R242">242</xref>]. The transcription factor COUP II is a canonical WNT target and represses PPAR γ expression [<xref ref-type="bibr" rid="R243">243</xref>]. In adipocytes, adiponectin increases PPAR γ expression and decreases LPS-induced NF-κB expression and IL-6 production [<xref ref-type="bibr" rid="R244">244</xref>].</p>
<sec id="s1_7_1">
<title>PPAR γ and fibrosis</title>
<p>An inverse relationship is observed between the expression of PPAR γ and the apparition of fibrosis. Aberrant downregulation of PPAR γ is correlated with the development of fibrosis in skin, lung, pancreas, heart, and liver [<xref ref-type="bibr" rid="R245">245</xref>]. PPAR γ□ expression is decreased in lung fibrosis [<xref ref-type="bibr" rid="R246">246</xref>], liver fibrosis [<xref ref-type="bibr" rid="R247">247</xref>], kidney fibrosis [<xref ref-type="bibr" rid="R248">248</xref>] and scarring alopecia fibrosis [<xref ref-type="bibr" rid="R249">249</xref>]. Furthermore, reduced PPAR γ expression precede fibrosis in several human diseases, suggesting a causal role [<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R250">250</xref>]. Fibroblasts, with a decreased level of PPAR γ, present an increase expression of TGF-β1, type 1 collagen, and α-SMA [<xref ref-type="bibr" rid="R251">251</xref>, <xref ref-type="bibr" rid="R252">252</xref>].</p>
<p>Several studies have shown, that PPAR γ agonists can diminish pro-fibrotic signal-induced collagen synthesis and can blunt fibrosis [<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R241">241</xref>, <xref ref-type="bibr" rid="R245">245</xref>, <xref ref-type="bibr" rid="R251">251</xref>, <xref ref-type="bibr" rid="R253">253</xref>–<xref ref-type="bibr" rid="R257">257</xref>]. PPAR γ natural and synthetic ligands, such as 15d-PGJ2 and rosiglitazone, can decrease the fibroblast-myofibroblast differentiation, synthesis of collagen and firbonectin and decrease the expression of TGF-β1 [<xref ref-type="bibr" rid="R247">247</xref>, <xref ref-type="bibr" rid="R248">248</xref>, <xref ref-type="bibr" rid="R253">253</xref>, <xref ref-type="bibr" rid="R258">258</xref>, <xref ref-type="bibr" rid="R259">259</xref>]. Moreover, 15d-PGJ2 and rosiglitazone decrease bleomycin-induced lung fibrosis [<xref ref-type="bibr" rid="R260">260</xref>]. PPAR γ agonists stop the TGF-β1-induced EMT of alveolar epithelial cells and decrease fibrosis in numerous organs such as heart [<xref ref-type="bibr" rid="R261">261</xref>, <xref ref-type="bibr" rid="R262">262</xref>], lung [<xref ref-type="bibr" rid="R263">263</xref>, <xref ref-type="bibr" rid="R264">264</xref>], liver [<xref ref-type="bibr" rid="R265">265</xref>, <xref ref-type="bibr" rid="R266">266</xref>] and kidney [<xref ref-type="bibr" rid="R267">267</xref>, <xref ref-type="bibr" rid="R268">268</xref>].</p>
</sec>
<sec id="s1_7_2">
<title>PPAR γ and radiation-induced fibrosis</title>
<p>Radiation therapy causes a downregulation of PPAR γ expression [<xref ref-type="bibr" rid="R59">59</xref>]. PPAR γ levels are decreased in 3 to 12 hours after a total body irradiation of C57BL/6 mice [<xref ref-type="bibr" rid="R59">59</xref>], after UVB irradiation in skin models [<xref ref-type="bibr" rid="R269">269</xref>] and in 3 days following a single abdominal dose of 10 Gy [<xref ref-type="bibr" rid="R270">270</xref>].</p>
<p>Oxidative stress and inflammation are involved in radiation-induced brain injury [<xref ref-type="bibr" rid="R271">271</xref>, <xref ref-type="bibr" rid="R272">272</xref>]. Administration of PPAR γ agonists, such as pioglitazone, can decrease the severity of radiation-induced cognitive impairment in rat models [<xref ref-type="bibr" rid="R273">273</xref>]. PPAR γ ligands block the radiation-induced activation of NF-κB [<xref ref-type="bibr" rid="R274">274</xref>]. PPAR γ agonists administration can contribute to reduce the inflammation and oxidative stress [<xref ref-type="bibr" rid="R248">248</xref>, <xref ref-type="bibr" rid="R275">275</xref>].</p>
<p>PPAR γ ligands enhance radiation-induced DNA damage in lung cancer cells <italic>in vitro</italic> [<xref ref-type="bibr" rid="R276">276</xref>, <xref ref-type="bibr" rid="R277">277</xref>].</p>
<p>PPAR γ activators can prevent irradiation-induced inflammatory processes through the inhibition of NF-κB expression and the downregulation of STAT-3 pathway, an activator of canonical WNT/β-catenin pathway [<xref ref-type="bibr" rid="R270">270</xref>]. Diosmin, a citrus bioflavonoid which has antioxidant, anti-inflammatory and anti-apoptotic properties [<xref ref-type="bibr" rid="R278">278</xref>], can increase PPAR γ expression and can decrease canonical WNT/β-catenin pathway to attenuate radiation-induced hepatic fibrosis [<xref ref-type="bibr" rid="R9">9</xref>].</p>
</sec>
</sec>
<sec id="s1_8">
<title>Interactions between PPAR γ and canonical WNT/β-catenin pathway</title>
<p>WNT/β-catenin pathway and PPAR γ act in an opposite manner in several diseases such as cancers [<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R279">279</xref>–<xref ref-type="bibr" rid="R284">284</xref>]. WNT/β-catenin pathway and PPAR γ interact through a TCF/LEF β-catenin domain and a catenin-binding domain within PPAR γ [<xref ref-type="bibr" rid="R285">285</xref>–<xref ref-type="bibr" rid="R288">288</xref>]. Downregulation of the WNT/β-catenin pathway induces PPAR γ stimulation while PPAR γ agonists decrease β-catenin expression in numerous cellular systems [<xref ref-type="bibr" rid="R235">235</xref>, <xref ref-type="bibr" rid="R236">236</xref>, <xref ref-type="bibr" rid="R289">289</xref>]. PPAR γ agonists can act as neuroprotective agents and promoting synaptic plasticity through a WNT/β-catenin/PI3K/Akt pathway interaction [<xref ref-type="bibr" rid="R290">290</xref>]. The regulation of mesenchymal stem cell differentiation also shows the existence of this crosstalk [<xref ref-type="bibr" rid="R291">291</xref>].</p>
<p>Indeed, in several diseases, β-catenin signaling inhibits PPAR γ [<xref ref-type="bibr" rid="R292">292</xref>–<xref ref-type="bibr" rid="R301">301</xref>], and using PPAR γ agonists is considered as promising treatment through this interplay [<xref ref-type="bibr" rid="R302">302</xref>]. Troglitazone, a PPAR γ agonist, can decrease c-Myc levels [<xref ref-type="bibr" rid="R303">303</xref>]. In intestinal fibrosis, the activation of WNT/β-catenin has been observed and the use of PPAR γ agonist can inhibit WNT/β-catenin pathway activation and then can repress fibrosis [<xref ref-type="bibr" rid="R304">304</xref>]. PPAR γ agonists stimulate Dickkopf-1 (DKK1) activity, which inhibits the canonical WNT pathway and then block fibroblast differentiation [<xref ref-type="bibr" rid="R305">305</xref>]. During adipogenesis in 3T3-L1 cells, PI3K/Akt pathway decreases PPAR γ expression [<xref ref-type="bibr" rid="R306">306</xref>]. Akt signaling participates to PPAR γ inhibition in adipocyte differentiation [<xref ref-type="bibr" rid="R307">307</xref>–<xref ref-type="bibr" rid="R309">309</xref>]. PI3K/Akt pathway phosphorylates GSK-3β and inhibits it, which decreases PPAR γ expression [<xref ref-type="bibr" rid="R176">176</xref>, <xref ref-type="bibr" rid="R310">310</xref>]. β-catenin signaling, through its activation of Akt signaling, inhibits PPAR γ expression in adipocytes and 2T2-L1 preadipocytes [<xref ref-type="bibr" rid="R289">289</xref>, <xref ref-type="bibr" rid="R311">311</xref>]. Moreover, inhibition of Akt pathway in 3T3-L1 cells activates the expression of PPAR γ [<xref ref-type="bibr" rid="R312">312</xref>]. PPAR γ agonists can decrease the activity of Akt signaling [<xref ref-type="bibr" rid="R313">313</xref>, <xref ref-type="bibr" rid="R314">314</xref>]. Rosiglitazone and pioglitazone, PPAR γ agonists, inhibit both Akt signaling and GSK-3β activity in cardiac fibrosis to block TGF-β–induced collagen accumulation [<xref ref-type="bibr" rid="R315">315</xref>].</p>
</sec>
<sec id="s1_9">
<title>Interactions between PPAR γ and TGF-β1</title>
<p>TGF-β1 upregulation decreases PPAR γ expression in fibroblasts [<xref ref-type="bibr" rid="R245">245</xref>] and hepatic stellate cells [<xref ref-type="bibr" rid="R316">316</xref>], whereas PPAR γ agonists can directly inhibit TGF-β1 activity [<xref ref-type="bibr" rid="R317">317</xref>], prevent expression and synthesis of collagen in fibroblasts [<xref ref-type="bibr" rid="R253">253</xref>, <xref ref-type="bibr" rid="R254">254</xref>, <xref ref-type="bibr" rid="R257">257</xref>], and then prevent α-SMA expression [<xref ref-type="bibr" rid="R253">253</xref>, <xref ref-type="bibr" rid="R257">257</xref>]. In addition, thiazolidinediones can reduce hepatic fibrosis through the inhibition of α-SMA and TGF-β expression [<xref ref-type="bibr" rid="R318">318</xref>]. PPAR γ agonists can inhibit both the Smad-dependent and Smad-independent TGF-β1 pathways.</p>
</sec>
<sec id="s1_10">
<title>Interactions through the Smad pathway</title>
<p>Anti-fibrotic PPAR γ effects can be largely explained through the Smad pathway. PPAR γ promoter has two Smad binding elements and inhibition of PPAR γ favors canonical Smad2/3 signaling [<xref ref-type="bibr" rid="R316">316</xref>].</p>
<p>In human hepatic stellate cells, PPAR γ agonists can inhibit TGF-β1/Smad3 signaling [<xref ref-type="bibr" rid="R319">319</xref>]. Smad-dependent collagen production is suppressed by PPAR γ ligand-activated through targeting the p300 transcriptional coactivator [<xref ref-type="bibr" rid="R254">254</xref>]. CDDO can prevent TGF-β1-induced fibrosis by inhibition of Smad transcription and Akt pathway [<xref ref-type="bibr" rid="R257">257</xref>]. TG-Interacting Factor (TGIF) which is a Smad transcriptional co-repressor can be activated by PPAR γ agonists, such as troglitazone, ciglitazone, and 15d-PGJ2. This leads to repress TGF-β1-induced fibrosis in hepatocyte cells [<xref ref-type="bibr" rid="R320">320</xref>, <xref ref-type="bibr" rid="R321">321</xref>]. TGF-β1-induced JNK pathway is decreased by troglitazone, which decreases Smad2 signaling and then impairs myofibroblasts differentiation [<xref ref-type="bibr" rid="R322">322</xref>]. In addition, adiponectin prevents fibrosis in liver in mice [<xref ref-type="bibr" rid="R323">323</xref>, <xref ref-type="bibr" rid="R324">324</xref>].</p>
<p>Moreover, a PPAR γ downregulation shows an increase of (increases) Smad3 and α-SMA expression and an overproduction of collagen (collagen overproduction) [<xref ref-type="bibr" rid="R252">252</xref>]. Rosiglitazone, a PPAR γ agonist, could decrease fibrosis by stimulating Smad7, an inhibitor of TGF/Smad signaling pathway [<xref ref-type="bibr" rid="R325">325</xref>]. In liver fibrosis, overexpression of prolyl oligopeptidase (POP) by S17092 (a POP inhibitor) leads to activate Smad7 protein and PPAR γ and then inactivates TGF-β signaling [<xref ref-type="bibr" rid="R326">326</xref>].</p>
</sec>
<sec id="s1_11">
<title>Interactions through the non-Smad pathway</title>
<p>PPAR γ agonists can induce diminution of TGF-β1expression in alveolar epithelial cells and in tumor metastasis without interacting with the Smad pathway [<xref ref-type="bibr" rid="R327">327</xref>, <xref ref-type="bibr" rid="R328">328</xref>]. In an independent Smad pathway manner, PPAR γ represses TGF-β1-induced fibrosis [<xref ref-type="bibr" rid="R253">253</xref>, <xref ref-type="bibr" rid="R258">258</xref>, <xref ref-type="bibr" rid="R317">317</xref>]. TGF-β1 expression can be inhibited by 15d-PGJ2 through a PTEN-mediated p70 ribosomal S6 kinase-1 inhibition [<xref ref-type="bibr" rid="R329">329</xref>]. PPAR γ agonists can decrease TGF-β1-induced myofibroblast differentiation via the inhibition of PI3K/Akt pathway [<xref ref-type="bibr" rid="R330">330</xref>]. PPAR γ agonists can stimulate PTEN expression for having anti-fibrosis effects [<xref ref-type="bibr" rid="R219">219</xref>, <xref ref-type="bibr" rid="R329">329</xref>, <xref ref-type="bibr" rid="R331">331</xref>], and leading to the inhibition of collagen production and myofibroblast differentiation [<xref ref-type="bibr" rid="R332">332</xref>].</p>
</sec>
<sec id="s1_12">
<title>Interactions between PPAR γ and canonical WNT/β-catenin pathway/TGF-β1 in radiation-induced fibrosis (cf. Figure <xref ref-type="fig" rid="F3">3</xref>)</title>
<p>Several studies have shown a crosstalk between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ [<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R250">250</xref>]. Indeed, canonical WNT/β-catenin is activated by TGF-β1, and this results in inhibition of PPAR γ. In liver fibrosis, TGF-β1 inhibits PPAR γ expression by increasing β-catenin expression [<xref ref-type="bibr" rid="R299">299</xref>]. In turn, activation of PPAR γ inhibits WNT/β-catenin pathway and then TGF-β1. PPAR γ targets PI3K/Akt for repress TGF-β1-induced myofibroblast differentiation [<xref ref-type="bibr" rid="R330">330</xref>]. PPAR γ agonists can inhibit fibrosis development through inactivation of TGF-β1 [<xref ref-type="bibr" rid="R333">333</xref>]. Moreover, 15-deoxy-delta12,14-prostaglandin J2, troglitazone, and rosiglitazone can suppress corneal myofibroblasts in eyes [<xref ref-type="bibr" rid="R294">294</xref>]. In addition, PPAR γ agonists can protect against excessive fibrosis [<xref ref-type="bibr" rid="R245">245</xref>]. Basic fibroblast growth factor (bFGF) can be repressed by using rosiglitazone and pioglitazone [<xref ref-type="bibr" rid="R313">313</xref>]. Inhibition of Akt pathway attenuates TGF-β signaling in rat kidney epithelial cells [<xref ref-type="bibr" rid="R334">334</xref>]. Troglitazone, a PPAR γ agonist, inhibits TGF-β signaling by phosphorylating Akt pathway at Ser437. LY294002, a PI3K inhibitor, inhibits Akt phosphorylation and α-SMA induction and then attenuates TGF-β1 signaling [<xref ref-type="bibr" rid="R335">335</xref>]. TGF-β-induced phosphorylation of β-catenin at Tyr654 associated with a conjunction between β-catenin and Smad3 stimulate α-SMA expression during EMT [<xref ref-type="bibr" rid="R336">336</xref>]. In fibrosis, troglitazone can inhibit TGF-β signaling by inhibiting β-catenin and PI3K/Akt pathway activation and by activating GSK-3β, the inhibitor of WNT pathway [<xref ref-type="bibr" rid="R335">335</xref>].</p>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<title>Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ agonists in radiation-induced fibrosis</title>
<p>Inflammation activates WNT ligands. WNT ligand binds FZL and LRP5/6 receptors. This leads to inactivate the destruction complex AXIN/APC/GSK-3β. β-catenin phosphorylation is thus stopped, which prevents its degradation in the proteasome. Then, β-catenin accumulates in the cytosol and translocates to the nucleus for binding TCF/LEF co-transcription factor for inducing WNT target genes such as c-Myc and cyclin D1. WNT pathway and PI3K/Akt pathway increase each other. Inflammation and DNA damage also activate TGF-β1, which induces the Smad pathway. TGF-β1 binds type 2 TGF-β receptor, which recruits type 1 TGF-β receptor. The heterotetramer formed phosphorylates Smad2/3, which binds to Smad4. The Smad complex translocates to the nucleus for activation its target genes, such as CTGF. PPAR γ agonists activate Dickkopf-1 (DKK) for the inhibition of WNT ligands, and prevent β-catenin accumulation by activating GSK-3β. PPAR γ agonists inhibit Akt activity and stimulate PTEN, the inhibitor of PI3K. PPAR γ agonists also stimulate Smad7 and PTEN for inhibiting Smad pathway. Adenomatous polyposis coli (APC); dishevelled (DSH); frizzled (FZD); glycogen synthase kinase-3β (GSK-3β); low-density lipoprotein receptor-related protein 5/6 (LRP5/6); peroxisome proliferator-activated receptor γ (PPARγ); TGF-β1 receptors 1 and 2 (R1, R2); T-cell factor /lymphoid enhancer factor (TCF/LEF); transforming growth factor (TGF); phosphatase and tensin homolog (PTEN).</p>
</caption>
<graphic xlink:href="oncotarget-08-90579-g003"></graphic>
</fig>
</sec>
</sec>
<sec id="s2">
<title>CONCLUSION</title>
<p>Radiation-induced fibrosis is characterized by DNA damage and inflammation. These two processes lead to the activation of TGF-β1 and canonical WNT/β-catenin pathway. TGF-β1 plays a major role in the differentiation of fibroblasts into myofibroblasts. Myofibroblasts appear able to physiological contraction and relaxation. However, in fibrosis myofibroblasts generate a phenomenon of contraction-retraction lasting without relaxation and with an irreversible retraction favored by the synthesis of collagen. Myofibroblasts show a main role in cellular fibrosis in numerous organs such as kidney, heart, lung, liver and wound. TGF-β1 operates in a canonical WNT/β-catenin pathway dependent manner. These two pathways stimulate each other through the Smad pathway or non-Smad pathways like PI3K/Akt pathway. TGF-β1 stimulates myofibroblast differentiation by the stimulation of canonical WNT pathway and the downregulation of PPAR γ expression. TGF-β1 appears to be an interesting therapeutic target in fibrosis [<xref ref-type="bibr" rid="R337">337</xref>, <xref ref-type="bibr" rid="R338">338</xref>]. PPAR γ agonists stimulate Smad7 for inhibiting Smads pathway what blocks TGF-β signaling. PPAR γ agonist can decrease canonical WNT/β-catenin pathway by activating both Smad 7, GSK-3β and DKK. PPAR γ agonists can also stimulate PTEN, an inhibitor of PI3K/Akt pathway and inhibit the Smad pathway for downregulation TGF-β1 expression. Thus, by both inhibiting TGF-β1 and the canonical WNT/β-catenin pathway, PPAR γ agonists could be interesting preventive targets for radiation-induced fibrosis treatment (cf. Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<title>PPAR γ interactions with TGF-β1, PI3K/Akt pathway and the canonical WNT/β-catenin pathway</title>
<p>PPAR γ agonists activate Smad7, an inhibitor of Smads pathway. PPAR γ agonists activate PTEN, which inhibits both PI3K/Akt pathway and TGF-β1 signaling. PPAR γ agonists activate DKK and Smad7, two inhibitors of WNT/beta-catenin pathway leading to the β-catenin degradation in the proteasome. PPAR γ agonists activate GSK-3β activity, which forms the destruction complex to degrade β-catenin. In contrast, presence of WNT ligands inhibits GSK-3β and lead to cytosolic accumulation of β-catenin. Then nuclear β-catenin associates with TCF/LEF in the nucleus to inhibit PPAR γ expression.</p>
</caption>
<graphic xlink:href="oncotarget-08-90579-g004"></graphic>
</fig>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="con">
<p>
<bold>Author contributions</bold>
</p>
<p>All the authors have contributed equally to this review.</p>
</fn>
<fn fn-type="COI-statement">
<p>
<bold>CONFLICTS OF INTEREST</bold>
</p>
<p>The authors declare no conflicts of interest.</p>
</fn>
</fn-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>APC</term>
<def>
<p>adenomatous polyposis coli</p>
</def>
</def-item>
<def-item>
<term>DSH</term>
<def>
<p>disheveled</p>
</def>
</def-item>
<def-item>
<term>FZD</term>
<def>
<p>frizzled</p>
</def>
</def-item>
<def-item>
<term>GSK-3β</term>
<def>
<p>glycogen synthase kinase-3β</p>
</def>
</def-item>
<def-item>
<term>LRP 5/6</term>
<def>
<p>low-density lipoprotein receptor-related protein 5/6</p>
</def>
</def-item>
<def-item>
<term>PI3K-Akt</term>
<def>
<p>phosphatidylinositol 3-kinase-protein kinase B</p>
</def>
</def-item>
<def-item>
<term>PPAR γ</term>
<def>
<p>peroxisome proliferator-activated receptor γ</p>
</def>
</def-item>
<def-item>
<term>RIF</term>
<def>
<p>radiation-induced fibrosis</p>
</def>
</def-item>
<def-item>
<term>TCF/LEF</term>
<def>
<p>T-cell factor/lymphoid enhancer factor</p>
</def>
</def-item>
<def-item>
<term>TGF-β</term>
<def>
<p>transforming growth factor β</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harper</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Jenrette</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Aguero</surname>
<given-names>EG</given-names>
</name>
</person-group>
<article-title>Skin toxicity during breast irradiation: pathophysiology and management</article-title>
<source/>South Med J
          <year>2004</year>
<volume>97</volume>
<fpage>989</fpage>
<lpage>93</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.SMJ.0000140866.97278.87">https://doi.org/10.1097/01.SMJ.0000140866.97278.87</ext-link>
</comment>
<pub-id pub-id-type="pmid">15558927</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pires</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Segreto</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Segreto</surname>
<given-names>HR</given-names>
</name>
</person-group>
<article-title>RTOG criteria to evaluate acute skin reaction and its risk factors in patients with breast cancer submitted to radiotherapy</article-title>
<source/>Rev Lat Am Enfermagem
          <year>2008</year>
<volume>16</volume>
<fpage>844</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">19061020</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wynn</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Fibrotic disease and the T(H)1/T(H)2 paradigm</article-title>
<source/>Nat Rev Immunol
          <year>2004</year>
<volume>4</volume>
<fpage>583</fpage>
<lpage>94</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nri1412">https://doi.org/10.1038/nri1412</ext-link>
</comment>
<pub-id pub-id-type="pmid">15286725</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wynn</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Cellular and molecular mechanisms of fibrosis</article-title>
<source/>J Pathol
          <year>2008</year>
<volume>214</volume>
<fpage>199</fpage>
<lpage>210</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/path.2277">https://doi.org/10.1002/path.2277</ext-link>
</comment>
<pub-id pub-id-type="pmid">18161745</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dörr</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hendry</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Consequential late effects in normal tissues</article-title>
<source/>Radiother Oncol
          <year>2001</year>
<volume>61</volume>
<fpage>223</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">11730991</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flanders</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sowers</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anzano</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Arabshahi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation</article-title>
<source/>Am J Pathol
          <year>2002</year>
<volume>160</volume>
<fpage>1057</fpage>
<lpage>68</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0002-9440(10)64926-7">https://doi.org/10.1016/S0002-9440(10)64926-7</ext-link>
</comment>
<pub-id pub-id-type="pmid">11891202</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Müller</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Meineke</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Radiation-induced alterations in cytokine production by skin cells</article-title>
<source/>Exp Hematol
          <year>2007</year>
<volume>35</volume>
<fpage>96</fpage>
<lpage>104</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.exphem.2007.01.017">https://doi.org/10.1016/j.exphem.2007.01.017</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hirschel</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Statkov</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Majno</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Granulation tissue as a contractile organ. A study of structure and function</article-title>
<source/>J Exp Med
          <year>1972</year>
<volume>135</volume>
<fpage>719</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">4336123</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasan</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Abdel-Rafei</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Galal</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling</article-title>
<source/>Biochem Cell Biol
          <year>2017</year>
<volume>95</volume>
<fpage>400</fpage>
<lpage>14</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1139/bcb-2016-0142">https://doi.org/10.1139/bcb-2016-0142</ext-link>
</comment>
<pub-id pub-id-type="pmid">28177765</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zampieri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Coen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The prehistory of the cytoskeleton concept</article-title>
<source/>Cytoskelet (Hoboken)
          <year>2014</year>
<volume>71</volume>
<fpage>464</fpage>
<lpage>71</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cm.21177">https://doi.org/10.1002/cm.21177</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Della Latta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Cecchettini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Del Ry</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions</article-title>
<source/>Pharmacol Res
          <year>2015</year>
<volume>97</volume>
<fpage>122</fpage>
<lpage>30</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.phrs.2015.04.012">https://doi.org/10.1016/j.phrs.2015.04.012</ext-link>
</comment>
<pub-id pub-id-type="pmid">25959210</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunwar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haston</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>DNA damage at respiratory distress, but not acute time-points, correlates with tissue fibrosis following thoracic radiation exposure in mice</article-title>
<source/>Int J Radiat Biol
          <year>2015</year>
<volume>91</volume>
<fpage>360</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/09553002.2015.997897">https://doi.org/10.3109/09553002.2015.997897</ext-link>
</comment>
<pub-id pub-id-type="pmid">25529973</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Povedano</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Mulero</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Blasco</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Mice with pulmonary fibrosis driven by telomere dysfunction</article-title>
<source/>Cell Rep
          <year>2015</year>
<volume>12</volume>
<fpage>286</fpage>
<lpage>99</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2015.06.028">https://doi.org/10.1016/j.celrep.2015.06.028</ext-link>
</comment>
<pub-id pub-id-type="pmid">26146081</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarnold</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brotons</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Pathogenetic mechanisms in radiation fibrosis</article-title>
<source/>Radiother Oncol
          <year>2010</year>
<volume>97</volume>
<fpage>149</fpage>
<lpage>61</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.radonc.2010.09.002">https://doi.org/10.1016/j.radonc.2010.09.002</ext-link>
</comment>
<pub-id pub-id-type="pmid">20888056</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chitra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saiprasad</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Manikandan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sudhandiran</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study</article-title>
<source/>Toxicol Lett
          <year>2013</year>
<volume>219</volume>
<fpage>178</fpage>
<lpage>93</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxlet.2013.03.009">https://doi.org/10.1016/j.toxlet.2013.03.009</ext-link>
</comment>
<pub-id pub-id-type="pmid">23523906</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haston</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>CXC receptor 1 and 2 and neutrophil elastase inhibitors alter radiation-induced lung disease in the mouse</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2013</year>
<volume>85</volume>
<fpage>215</fpage>
<lpage>22</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2012.02.024">https://doi.org/10.1016/j.ijrobp.2012.02.024</ext-link>
</comment>
<pub-id pub-id-type="pmid">22929857</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graves</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Anscher</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Movsas</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Radiation pulmonary toxicity: from mechanisms to management</article-title>
<source/>Semin Radiat Oncol
          <year>2010</year>
<volume>20</volume>
<fpage>201</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.semradonc.2010.01.010">https://doi.org/10.1016/j.semradonc.2010.01.010</ext-link>
</comment>
<pub-id pub-id-type="pmid">20685583</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paun</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kunwar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haston</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>Acute adaptive immune response correlates with late radiation-induced pulmonary fibrosis in mice</article-title>
<source/>Radiat Oncol
          <year>2015</year>
<volume>10</volume>
<fpage>45</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13014-015-0359-y">https://doi.org/10.1186/s13014-015-0359-y</ext-link>
</comment>
<pub-id pub-id-type="pmid">25889053</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and -sensitive mice after thoracic irradiation</article-title>
<source/>Exp Lung Res
          <year>1998</year>
<volume>24</volume>
<fpage>321</fpage>
<lpage>37</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/01902149809041538">https://doi.org/10.3109/01902149809041538</ext-link>
</comment>
<pub-id pub-id-type="pmid">9635254</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Okunieff</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families</article-title>
<source/>Radiat Res
          <year>2002</year>
<volume>157</volume>
<fpage>256</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">11839087</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koerdt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rohleder</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Rommel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nobis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stoeckelhuber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pigorsch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duma</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Kesting</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>An expression analysis of markers of radiation-induced skin fibrosis and angiogenesis in wound healing disorders of the head and neck</article-title>
<source/>Radiat Oncol
          <year>2015</year>
<volume>10</volume>
<fpage>202</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13014-015-0508-3">https://doi.org/10.1186/s13014-015-0508-3</ext-link>
</comment>
<pub-id pub-id-type="pmid">26390925</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straub</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>New</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Lominska</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shnayder</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Radiation-induced fibrosis: mechanisms and implications for therapy</article-title>
<source/>J Cancer Res Clin Oncol
          <year>2015</year>
<volume>141</volume>
<fpage>1985</fpage>
<lpage>94</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00432-015-1974-6">https://doi.org/10.1007/s00432-015-1974-6</ext-link>
</comment>
<pub-id pub-id-type="pmid">25910988</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Andrade</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>IP</given-names>
</name>
<name>
<surname>de Moraes</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>do Nascimento</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Salata</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>de Carvalho</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>de Almeida</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>Radiotherapy-induced skin reactions induce fibrosis mediated by TGF-β1 ytokine</article-title>
<source/>Dose Response
          <year>2017</year>
<fpage>15</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1559325817705019">https://doi.org/10.1177/1559325817705019</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Duthoit</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction</article-title>
<source/>Front Physiol
          <year>2014</year>
<volume>5</volume>
<fpage>429</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2014.00429">https://doi.org/10.3389/fphys.2014.00429</ext-link>
</comment>
<pub-id pub-id-type="pmid">25414671</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Regulation of matrix remodeling by peroxisome proliferator-activated receptor-γ: a novel link between metabolism and fibrogenesis</article-title>
<source/>Open Rheumatol J
          <year>2012</year>
<volume>6</volume>
<fpage>103</fpage>
<lpage>15</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2174/1874312901206010103">https://doi.org/10.2174/1874312901206010103</ext-link>
</comment>
<pub-id pub-id-type="pmid">22802908</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubblefield</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors</article-title>
<source/>PM R
          <year>2011</year>
<volume>3</volume>
<fpage>1041</fpage>
<lpage>54</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pmrj.2011.08.535">https://doi.org/10.1016/j.pmrj.2011.08.535</ext-link>
</comment>
<pub-id pub-id-type="pmid">22108231</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westbury</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Yarnold</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Radiation fibrosis—current clinical and therapeutic perspectives</article-title>
<source/>Clin Oncol (R Coll Radiol)
          <year>2012</year>
<volume>24</volume>
<fpage>657</fpage>
<lpage>72</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clon.2012.04.001">https://doi.org/10.1016/j.clon.2012.04.001</ext-link>
</comment>
<pub-id pub-id-type="pmid">22608361</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borger</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kemperman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Smitt</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Dongen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lebesque</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bartelink</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Dose and volume effects on fibrosis after breast conservation therapy</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>1994</year>
<volume>30</volume>
<fpage>1073</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">7961014</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Turcotte</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Catton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chabot</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wunder</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benk</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goddard</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sadura</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma</article-title>
<source/>Radiother Oncol
          <year>2005</year>
<volume>75</volume>
<fpage>48</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">15948265</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geara</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Komaki</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Travis</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>1998</year>
<volume>41</volume>
<fpage>279</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">9607342</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Purdy</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Emami</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Harms</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lockett</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>1999</year>
<volume>45</volume>
<fpage>323</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">10487552</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Svensson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Denekamp</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2002</year>
<volume>52</volume>
<fpage>1207</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">11955731</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gold</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Osborn</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Radiotherapy for malignancy in patients with scleroderma: the Mayo Clinic experience</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2007</year>
<volume>67</volume>
<fpage>559</fpage>
<lpage>67</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2006.09.003">https://doi.org/10.1016/j.ijrobp.2006.09.003</ext-link>
</comment>
<pub-id pub-id-type="pmid">17236971</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suarez</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Knackstedt</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Jenrette</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Significant fibrosis after radiation therapy in a patient with Marfan syndrome</article-title>
<source/>Radiat Oncol J
          <year>2014</year>
<volume>32</volume>
<fpage>208</fpage>
<lpage>12</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3857/roj.2014.32.3.208">https://doi.org/10.3857/roj.2014.32.3.208</ext-link>
</comment>
<pub-id pub-id-type="pmid">25324993</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreassen</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alsner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Herskind</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cesaretti</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Atencio</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Formenti</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Rosenstein</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2006</year>
<volume>64</volume>
<fpage>776</fpage>
<lpage>83</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2005.09.014">https://doi.org/10.1016/j.ijrobp.2005.09.014</ext-link>
</comment>
<pub-id pub-id-type="pmid">16338099</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edvardsen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tefre</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haffty</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Fosså</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Kristensen</surname>
<given-names>VN</given-names>
</name>
<name>
<surname>Børresen-Dale</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence</article-title>
<source/>Radiat Oncol
          <year>2007</year>
<volume>2</volume>
<fpage>25</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1748-717X-2-25">https://doi.org/10.1186/1748-717X-2-25</ext-link>
</comment>
<pub-id pub-id-type="pmid">17623063</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azria</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gourgou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sozzi</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Zouhair</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mirimanoff</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Kramar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lemanski</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dubois</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Romieu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pelegrin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ozsahin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients</article-title>
<source/>Br J Cancer
          <year>2004</year>
<volume>91</volume>
<fpage>1251</fpage>
<lpage>60</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.bjc.6602146">https://doi.org/10.1038/sj.bjc.6602146</ext-link>
</comment>
<pub-id pub-id-type="pmid">15328527</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheuk</surname>
<given-names>IW</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>VW</given-names>
</name>
</person-group>
<article-title>Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinoma</article-title>
<source/>Mol Clin Oncol
          <year>2014</year>
<volume>2</volume>
<fpage>553</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/mco.2014.276">https://doi.org/10.3892/mco.2014.276</ext-link>
</comment>
<pub-id pub-id-type="pmid">24940494</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwakawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oohira</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Strain dependent differences in a histological study of CD44 and collagen fibers with an expression analysis of inflammatory response-related genes in irradiated murine lung</article-title>
<source/>J Radiat Res
          <year>2004</year>
<volume>45</volume>
<fpage>423</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">15613788</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weigel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schmezer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Plass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Popanda</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Epigenetics in radiation-induced fibrosis</article-title>
<source/>Oncogene
          <year>2015</year>
<volume>34</volume>
<fpage>2145</fpage>
<lpage>55</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2014.145">https://doi.org/10.1038/onc.2014.145</ext-link>
</comment>
<pub-id pub-id-type="pmid">24909163</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edvardsen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Landmark-Høyvik</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Reinertsen</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Grenaker-Alnæs</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Nebdal</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Syvänen</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Rødningen</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Alsner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Borresen-Dale</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Fosså</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Kristensen</surname>
<given-names>VN</given-names>
</name>
</person-group>
<article-title>SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2013</year>
<volume>86</volume>
<fpage>791</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2013.02.025">https://doi.org/10.1016/j.ijrobp.2013.02.025</ext-link>
</comment>
<pub-id pub-id-type="pmid">23597419</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Depondt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lefaix</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial</article-title>
<source/>Head Neck
          <year>2005</year>
<volume>27</volume>
<fpage>114</fpage>
<lpage>23</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/hed.20121">https://doi.org/10.1002/hed.20121</ext-link>
</comment>
<pub-id pub-id-type="pmid">15641107</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lefaix</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate</article-title>
<source/>Br J Radiol
          <year>2002</year>
<volume>75</volume>
<fpage>467</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1259/bjr.75.893.750467">https://doi.org/10.1259/bjr.75.893.750467</ext-link>
</comment>
<pub-id pub-id-type="pmid">12036843</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Phurailatpam</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghosh-Laskar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Budrukkar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dinshaw</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Prabhash</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chaturvedi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>D’Cruz</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial</article-title>
<source/>Radiother Oncol
          <year>2012</year>
<volume>104</volume>
<fpage>343</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.radonc.2012.07.001">https://doi.org/10.1016/j.radonc.2012.07.001</ext-link>
</comment>
<pub-id pub-id-type="pmid">22853852</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Hershock</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Machtay</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chalian</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kligerman</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Berlin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>DI</given-names>
</name>
</person-group>
<article-title>Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument</article-title>
<source/>Am J Clin Oncol
          <year>2006</year>
<volume>29</volume>
<fpage>158</fpage>
<lpage>62</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.coc.0000207424.62275.9d">https://doi.org/10.1097/01.coc.0000207424.62275.9d</ext-link>
</comment>
<pub-id pub-id-type="pmid">16601435</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenthal</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Lewin</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Eisbruch</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer</article-title>
<source/>J Clin Oncol
          <year>2006</year>
<volume>24</volume>
<fpage>2636</fpage>
<lpage>43</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2006.06.0079">https://doi.org/10.1200/JCO.2006.06.0079</ext-link>
</comment>
<pub-id pub-id-type="pmid">16763277</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vainshtein</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>FY</given-names>
</name>
<name>
<surname>Vineberg</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Chepeha</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Eisbruch</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2014</year>
<volume>89</volume>
<fpage>973</fpage>
<lpage>80</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2014.03.013">https://doi.org/10.1016/j.ijrobp.2014.03.013</ext-link>
</comment>
<pub-id pub-id-type="pmid">24803039</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abratt</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Silvestri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Willcox</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Pulmonary complications of radiation therapy</article-title>
<source/>Clin Chest Med
          <year>2004</year>
<volume>25</volume>
<fpage>167</fpage>
<lpage>77</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0272-5231(03)00126-6">https://doi.org/10.1016/S0272-5231(03)00126-6</ext-link>
</comment>
<pub-id pub-id-type="pmid">15062608</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bravard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Luccioni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lefaix</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage</article-title>
<source/>Radiother Oncol
          <year>1998</year>
<volume>47</volume>
<fpage>255</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">9681888</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coia</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Myerson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Tepper</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Late effects of radiation therapy on the gastrointestinal tract</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>1995</year>
<volume>31</volume>
<fpage>1213</fpage>
<lpage>36</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0360-3016(94)00419-L">https://doi.org/10.1016/0360-3016(94)00419-L</ext-link>
</comment>
<pub-id pub-id-type="pmid">7713784</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marks</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Dugan</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Anscher</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>1995</year>
<volume>31</volume>
<fpage>1257</fpage>
<lpage>80</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0360-3016(94)00431-J">https://doi.org/10.1016/0360-3016(94)00431-J</ext-link>
</comment>
<pub-id pub-id-type="pmid">7713787</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pötter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Knocke</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Fellner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baldass</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reinthaller</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kucera</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations</article-title>
<source/>Cancer Radiother
          <year>2000</year>
<volume>4</volume>
<fpage>159</fpage>
<lpage>72</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1278-3218(00)88900-3">https://doi.org/10.1016/S1278-3218(00)88900-3</ext-link>
</comment>
<pub-id pub-id-type="pmid">10812362</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ridner</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria</article-title>
<source/>Eur J Oncol Nurs
          <year>2015</year>
<volume>19</volume>
<fpage>75</fpage>
<lpage>80</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejon.2014.07.006">https://doi.org/10.1016/j.ejon.2014.07.006</ext-link>
</comment>
<pub-id pub-id-type="pmid">25190635</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lefaix</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Current management for late normal tissue injury: radiation-induced fibrosis and necrosis</article-title>
<source/>Semin Radiat Oncol
          <year>2007</year>
<volume>17</volume>
<fpage>99</fpage>
<lpage>107</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.semradonc.2006.11.006">https://doi.org/10.1016/j.semradonc.2006.11.006</ext-link>
</comment>
<pub-id pub-id-type="pmid">17395040</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Travis</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Organizational response of normal tissues to irradiation</article-title>
<source/>Semin Radiat Oncol
          <year>2001</year>
<volume>11</volume>
<fpage>184</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">11447575</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>EP</given-names>
</name>
</person-group>
<article-title>Chronic oxidative stress after irradiation: an unproven hypothesis</article-title>
<source/>Med Hypotheses
          <year>2013</year>
<volume>80</volume>
<fpage>172</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mehy.2012.11.022">https://doi.org/10.1016/j.mehy.2012.11.022</ext-link>
</comment>
<pub-id pub-id-type="pmid">23245910</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tak</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>The use of ebselen for radioprotection in cultured cells and mice</article-title>
<source/>Free Radic Biol Med
          <year>2009</year>
<volume>46</volume>
<fpage>1177</fpage>
<lpage>85</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2009.01.023">https://doi.org/10.1016/j.freeradbiomed.2009.01.023</ext-link>
</comment>
<pub-id pub-id-type="pmid">19439217</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terasaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ohsawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Terasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dedong</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Urushiyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Amenomori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaneko-Togashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuwahara</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kamimura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2011</year>
<volume>301</volume>
<fpage>L415</fpage>
<lpage>26</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajplung.00008.2011">https://doi.org/10.1152/ajplung.00008.2011</ext-link>
</comment>
<pub-id pub-id-type="pmid">21764987</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications</article-title>
<source/>Curr Med Chem
          <year>2009</year>
<volume>16</volume>
<fpage>130</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">19149566</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chittezhath</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuttan</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Radioprotective activity of naturally occurring organosulfur compounds</article-title>
<source/>Tumori
          <year>2006</year>
<volume>92</volume>
<fpage>163</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">16724697</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberger</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Review</surname>
<given-names>Epperly MW</given-names>
</name>
</person-group>
<article-title>Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization</article-title>
<source/>
<italic>In Vivo</italic>
<year>2007</year>
<volume>21</volume>
<fpage>141</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">17436562</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudière</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ferrari-Iliou</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Intracellular antioxidants: from chemical to biochemical mechanisms</article-title>
<source/>Food Chem Toxicol
          <year>1999</year>
<volume>37</volume>
<fpage>949</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">10541450</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darley-Usmar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Halliwell</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system</article-title>
<source/>Pharm Res
          <year>1996</year>
<volume>13</volume>
<fpage>649</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">8860419</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Halliwell</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Free radicals and hearing. Cause, consequence, and criteria</article-title>
<source/>Ann N Y Acad Sci
          <year>1999</year>
<volume>884</volume>
<fpage>19</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">10842581</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denham</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Hauer-Jensen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The radiotherapeutic injury--a complex “wound.”</article-title>
<source/>Radiother Oncol
          <year>2002</year>
<volume>63</volume>
<fpage>129</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">12063002</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction?</article-title>
<source/>Curr Drug Targets
          <year>2010</year>
<volume>11</volume>
<fpage>1386</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">20583979</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boerma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hauer-Jensen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Potential targets for intervention in radiation-induced heart disease</article-title>
<source/>Curr Drug Targets
          <year>2010</year>
<volume>11</volume>
<fpage>1405</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">20583977</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lefaix</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Daburon</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Diagnosis of acute localized irradiation lesions: review of the French experimental experience</article-title>
<source/>Health Phys
          <year>1998</year>
<volume>75</volume>
<fpage>375</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">9753360</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abreu</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Fukata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arditi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>TLR signaling in the gut in health and disease</article-title>
<source/>J Immunol
          <year>2005</year>
<volume>174</volume>
<fpage>4453</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">15814663</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amadeu</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Seabra</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Monte-Alto-Costa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Nitric oxide donor improves healing if applied on inflammatory and proliferative phase</article-title>
<source/>J Surg Res
          <year>2008</year>
<volume>149</volume>
<fpage>84</fpage>
<lpage>93</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jss.2007.10.015">https://doi.org/10.1016/j.jss.2007.10.015</ext-link>
</comment>
<pub-id pub-id-type="pmid">18374944</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calveley</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>IW</given-names>
</name>
<name>
<surname>Vandyk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation</article-title>
<source/>Int J Radiat Biol
          <year>2005</year>
<volume>81</volume>
<fpage>887</fpage>
<lpage>99</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/09553000600568002">https://doi.org/10.1080/09553000600568002</ext-link>
</comment>
<pub-id pub-id-type="pmid">16524844</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oberdörster</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Particulate-cell interactions and pulmonary cytokine expression</article-title>
<source/>Environ Health Perspect
          <year>1997</year>
<volume>105</volume>
<fpage>1179</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">9400720</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olman</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>White</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matthay</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1</article-title>
<source/>Chest
          <year>2002</year>
<volume>121</volume>
<fpage>69S</fpage>
<lpage>70S</lpage>
<pub-id pub-id-type="pmid">11893691</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porter</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Ramsey</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McLaurin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Landsittel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Teass</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Castranova</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Time course of pulmonary response of rats to inhalation of crystalline silica: NF-kappa B activation, inflammation, cytokine production, and damage</article-title>
<source/>Inhal Toxicol
          <year>2002</year>
<volume>14</volume>
<fpage>349</fpage>
<lpage>67</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/08958370252870998">https://doi.org/10.1080/08958370252870998</ext-link>
</comment>
<pub-id pub-id-type="pmid">12028809</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Piedboeuf</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Baggs</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation</article-title>
<source/>Radiat Res
          <year>1996</year>
<volume>145</volume>
<fpage>762</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">8643837</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalash</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Berhane</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Houghton</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Epperly</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sprachman</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Wipf</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Franicola</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Greenberger</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Effects of thoracic irradiation on pulmonary endothelial compared to alveolar type-II cells in fibrosis-prone C57BL/6NTac mice</article-title>
<source/>
<italic>In Vivo</italic>
<year>2013</year>
<volume>27</volume>
<fpage>291</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">23606683</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalash</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Berhane</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rhieu</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Epperly</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Franicola</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shinde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Greenberger</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice</article-title>
<source/>
<italic>In Vivo</italic>
<year>2014</year>
<volume>28</volume>
<fpage>147</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">24632969</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>1995</year>
<volume>33</volume>
<fpage>99</fpage>
<lpage>109</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0360-3016(95)00095-G">https://doi.org/10.1016/0360-3016(95)00095-G</ext-link>
</comment>
<pub-id pub-id-type="pmid">7642437</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>FO</given-names>
</name>
</person-group>
<article-title>Alternative activation of macrophages: mechanism and functions</article-title>
<source/>Immunity
          <year>2010</year>
<volume>32</volume>
<fpage>593</fpage>
<lpage>604</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2010.05.007">https://doi.org/10.1016/j.immuni.2010.05.007</ext-link>
</comment>
<pub-id pub-id-type="pmid">20510870</pub-id>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sica</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mantovani</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Macrophage plasticity and polarization: <italic>in vivo</italic> veritas</article-title>
<source/>J Clin Invest
          <year>2012</year>
<volume>122</volume>
<fpage>787</fpage>
<lpage>95</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI59643">https://doi.org/10.1172/JCI59643</ext-link>
</comment>
<pub-id pub-id-type="pmid">22378047</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Alternative activation of macrophages: immune function and cellular biology</article-title>
<source/>Immunobiology
          <year>2009</year>
<volume>214</volume>
<fpage>630</fpage>
<lpage>41</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.imbio.2008.11.009">https://doi.org/10.1016/j.imbio.2008.11.009</ext-link>
</comment>
<pub-id pub-id-type="pmid">19264378</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jendrossek</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Belka</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The role of PDGF in radiation oncology</article-title>
<source/>Radiat Oncol
          <year>2007</year>
<volume>2</volume>
<fpage>5</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1748-717X-2-5">https://doi.org/10.1186/1748-717X-2-5</ext-link>
</comment>
<pub-id pub-id-type="pmid">17217530</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Sanjabi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Transforming growth factor-beta regulation of immune responses</article-title>
<source/>Annu Rev Immunol
          <year>2006</year>
<volume>24</volume>
<fpage>99</fpage>
<lpage>146</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.immunol.24.021605.090737">https://doi.org/10.1146/annurev.immunol.24.021605.090737</ext-link>
</comment>
<pub-id pub-id-type="pmid">16551245</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dadrich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nicolay</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Flechsig</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bickelhaupt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoeltgen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tietz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jenne</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Roehrich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wirkner</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Lahn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>PE</given-names>
</name>
</person-group>
<article-title>Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis</article-title>
<source/>Oncoimmunology
          <year>2016</year>
<volume>5</volume>
<fpage>e1123366</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/2162402X.2015.1123366">https://doi.org/10.1080/2162402X.2015.1123366</ext-link>
</comment>
<pub-id pub-id-type="pmid">27467922</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rube</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Uthe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Wessel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schuck</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Willich</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rube</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2000</year>
<volume>47</volume>
<fpage>1033</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">10863076</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thornton</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Foulcher</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Penny</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Breit</surname>
<given-names>SN</given-names>
</name>
</person-group>
<article-title>Both <italic>in vitro</italic> and <italic>in vivo</italic> irradiation are associated with induction of macrophage-derived fibroblast growth factors</article-title>
<source/>Clin Exp Immunol
          <year>1996</year>
<volume>103</volume>
<fpage>67</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">8565289</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Bedoya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Danielpour</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Remick</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ulich</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>Radiation-induced lung injury <italic>in vivo</italic>: expression of transforming growth factor-beta precedes fibrosis</article-title>
<source/>Inflammation
          <year>1996</year>
<volume>20</volume>
<fpage>339</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="pmid">8872498</pub-id>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campana</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zervoudis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Perdereau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fourquet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Badiu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tsakiris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Koulaloglou</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis</article-title>
<source/>J Cell Mol Med
          <year>2004</year>
<volume>8</volume>
<fpage>109</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">15090266</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodemann</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Bamberg</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cellular basis of radiation-induced fibrosis</article-title>
<source/>Radiother Oncol
          <year>1995</year>
<volume>35</volume>
<fpage>83</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">7569029</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomasek</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chaponnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Myofibroblasts and mechano-regulation of connective tissue remodelling</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2002</year>
<volume>3</volume>
<fpage>349</fpage>
<lpage>63</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrm809">https://doi.org/10.1038/nrm809</ext-link>
</comment>
<pub-id pub-id-type="pmid">11988769</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darby</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Hewitson</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Fibroblast differentiation in wound healing and fibrosis</article-title>
<source/>Int Rev Cytol
          <year>2007</year>
<volume>257</volume>
<fpage>143</fpage>
<lpage>79</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0074-7696(07)57004-X">https://doi.org/10.1016/S0074-7696(07)57004-X</ext-link>
</comment>
<pub-id pub-id-type="pmid">17280897</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chithra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sajithlal</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Chandrakasan</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Influence of Aloe vera on the glycosaminoglycans in the matrix of healing dermal wounds in rats</article-title>
<source/>J Ethnopharmacol
          <year>1998</year>
<volume>59</volume>
<fpage>179</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">9507902</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lefaix</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delanian</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2000</year>
<volume>47</volume>
<fpage>277</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">10802350</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pardo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Selman</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Matrix metalloproteases in aberrant fibrotic tissue remodeling</article-title>
<source/>Proc Am Thorac Soc
          <year>2006</year>
<volume>3</volume>
<fpage>383</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1513/pats.200601-012TK">https://doi.org/10.1513/pats.200601-012TK</ext-link>
</comment>
<pub-id pub-id-type="pmid">16738205</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuutila</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vuola</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kankuri</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Human wound-healing research: issues and perspectives for studies using wide-scale analytic platforms</article-title>
<source/>Adv Wound Care
          <year>2014</year>
<volume>3</volume>
<fpage>264</fpage>
<lpage>71</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/wound.2013.0502">https://doi.org/10.1089/wound.2013.0502</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ran</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The effects of total-body irradiation on the survival and skin wound healing of rats with combined radiation-wound injury</article-title>
<source/>J Trauma
          <year>2004</year>
<volume>57</volume>
<fpage>1087</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">15580037</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finlay</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Thannickal</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Fanburg</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Paulson</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor</article-title>
<source/>J Biol Chem
          <year>2000</year>
<volume>275</volume>
<fpage>27650</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M000893200">https://doi.org/10.1074/jbc.M000893200</ext-link>
</comment>
<pub-id pub-id-type="pmid">10862759</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Löffler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bamberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rodemann</surname>
<given-names>HP</given-names>
</name>
</person-group>
<article-title>Molecular and cellular basis of radiation fibrosis</article-title>
<source/>Int J Radiat Biol
          <year>1998</year>
<volume>73</volume>
<fpage>401</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">9587078</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudolph</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vande Berg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Poolman</surname>
<given-names>WL</given-names>
</name>
</person-group>
<article-title>Slowed growth of cultured fibroblasts from human radiation wounds</article-title>
<source/>Plast Reconstr Surg
          <year>1988</year>
<volume>82</volume>
<fpage>669</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">3420190</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toussaint</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Remacle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dierick</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Pascal</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Frippiat</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Royer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chainiaux</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Approach of evolutionary theories of ageing, stress, senescence-like phenotypes, calorie restriction and hormesis from the view point of far-from-equilibrium thermodynamics</article-title>
<source/>Mech Ageing Dev
          <year>2002</year>
<volume>123</volume>
<fpage>937</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">12044942</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bentzen</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity</article-title>
<source/>Eur J Cancer
          <year>1993</year>
<volume>29A</volume>
<fpage>1373</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">8398261</pub-id>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bentzen</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Relationship between early and late normal-tissue injury after postmastectomy radiotherapy</article-title>
<source/>Radiother Oncol
          <year>1991</year>
<volume>20</volume>
<fpage>159</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">1852907</pub-id>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourhis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lapeyre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tortochaux</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rives</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aghili</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bourdin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lesaunier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Benassi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lemanski</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Geoffrois</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lusinchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Verrelle</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bardet</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial</article-title>
<source/>J Clin Oncol
          <year>2006</year>
<volume>24</volume>
<fpage>2873</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2006.08.057">https://doi.org/10.1200/JCO.2006.08.057</ext-link>
</comment>
<pub-id pub-id-type="pmid">16782926</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcellos-Hoff</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues</article-title>
<source/>Radiat Res
          <year>1998</year>
<volume>150</volume>
<fpage>S109</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">9806614</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beach</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Groves</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Radiation induced pulmonary fibrosis as a model of progressive fibrosis: contributions of DNA damage, inflammatory response and cellular senescence genes</article-title>
<source/>Exp Lung Res
          <year>2017</year>
<fpage>1</fpage>
<lpage>16</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/01902148.2017.1318975">https://doi.org/10.1080/01902148.2017.1318975</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>LQ</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms and treatment of radiation-induced lung fibrosis</article-title>
<source/>Curr Drug Targets
          <year>2013</year>
<volume>14</volume>
<fpage>1347</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">23909719</pub-id>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcellos-Hoff</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Derynck</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Weatherbee</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Transforming growth factor-beta activation in irradiated murine mammary gland</article-title>
<source/>J Clin Invest
          <year>1994</year>
<volume>93</volume>
<fpage>892</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI117045">https://doi.org/10.1172/JCI117045</ext-link>
</comment>
<pub-id pub-id-type="pmid">8113421</pub-id>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guix</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rinehart</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dugger</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Chytil</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moses</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Arteaga</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression</article-title>
<source/>J Clin Invest
          <year>2007</year>
<volume>117</volume>
<fpage>1305</fpage>
<lpage>13</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI30740">https://doi.org/10.1172/JCI30740</ext-link>
</comment>
<pub-id pub-id-type="pmid">17415413</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guix</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rinehart</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dugger</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Chytil</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moses</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Arteaga</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression</article-title>
<source/>J Clin Invest
          <year>2017</year>
<volume>127</volume>
<fpage>1116</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI93333">https://doi.org/10.1172/JCI93333</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Travis</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Rachakonda</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Korhonen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sekhar</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>NRF2 deficiency reduces life span of mice administered thoracic irradiation</article-title>
<source/>Free Radic Biol Med
          <year>2011</year>
<volume>51</volume>
<fpage>1175</fpage>
<lpage>83</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2011.05.038">https://doi.org/10.1016/j.freeradbiomed.2011.05.038</ext-link>
</comment>
<pub-id pub-id-type="pmid">21712086</pub-id>
</element-citation>
</ref>
<ref id="R111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhowmick</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Ghiassi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bakin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aakre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lundquist</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Arteaga</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Moses</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism</article-title>
<source/>Mol Biol Cell
          <year>2001</year>
<volume>12</volume>
<fpage>27</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">11160820</pub-id>
</element-citation>
</ref>
<ref id="R112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janda</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Killisch</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jechlinger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Herzig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Downward</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Beug</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Grünert</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways</article-title>
<source/>J Cell Biol
          <year>2002</year>
<volume>156</volume>
<fpage>299</fpage>
<lpage>313</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.200109037">https://doi.org/10.1083/jcb.200109037</ext-link>
</comment>
<pub-id pub-id-type="pmid">11790801</pub-id>
</element-citation>
</ref>
<ref id="R113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zavadil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Böttinger</surname>
<given-names>EP</given-names>
</name>
</person-group>
<article-title>TGF-beta and epithelial-to-mesenchymal transitions</article-title>
<source/>Oncogene
          <year>2005</year>
<volume>24</volume>
<fpage>5764</fpage>
<lpage>74</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1208927">https://doi.org/10.1038/sj.onc.1208927</ext-link>
</comment>
<pub-id pub-id-type="pmid">16123809</pub-id>
</element-citation>
</ref>
<ref id="R114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagarajan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>ERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition</article-title>
<source/>Free Radic Biol Med
          <year>2012</year>
<volume>52</volume>
<fpage>983</fpage>
<lpage>92</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2011.11.024">https://doi.org/10.1016/j.freeradbiomed.2011.11.024</ext-link>
</comment>
<pub-id pub-id-type="pmid">22198183</pub-id>
</element-citation>
</ref>
<ref id="R115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Thannickal</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bochaton-Piallat</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The myofibroblast: one function, multiple origins</article-title>
<source/>Am J Pathol
          <year>2007</year>
<volume>170</volume>
<fpage>1807</fpage>
<lpage>16</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2007.070112">https://doi.org/10.2353/ajpath.2007.070112</ext-link>
</comment>
<pub-id pub-id-type="pmid">17525249</pub-id>
</element-citation>
</ref>
<ref id="R116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Thannickal</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Prunotto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Desmoulière</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
<name>
<surname>De Wever</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mareel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Recent developments in myofibroblast biology: paradigms for connective tissue remodeling</article-title>
<source/>Am J Pathol
          <year>2012</year>
<volume>180</volume>
<fpage>1340</fpage>
<lpage>55</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajpath.2012.02.004">https://doi.org/10.1016/j.ajpath.2012.02.004</ext-link>
</comment>
<pub-id pub-id-type="pmid">22387320</pub-id>
</element-citation>
</ref>
<ref id="R117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geraci</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Mariano</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury</article-title>
<source/>Radiat Res
          <year>1993</year>
<volume>136</volume>
<fpage>205</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">8248477</pub-id>
</element-citation>
</ref>
<ref id="R118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arora</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Qureshi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>WY</given-names>
</name>
</person-group>
<article-title>Coordinated regulation of ATF2 by miR-26b in γ-irradiated lung cancer cells</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e23802</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0023802">https://doi.org/10.1371/journal.pone.0023802</ext-link>
</comment>
<pub-id pub-id-type="pmid">21901137</pub-id>
</element-citation>
</ref>
<ref id="R119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>CO</given-names>
</name>
</person-group>
<article-title>Early alteration in TGF-beta mRNA expression in irradiated rat liver</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2000</year>
<volume>46</volume>
<fpage>639</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">10701743</pub-id>
</element-citation>
</ref>
<ref id="R120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibrosis</article-title>
<source/>World J Gastroenterol
          <year>2005</year>
<volume>11</volume>
<fpage>2634</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">15849824</pub-id>
</element-citation>
</ref>
<ref id="R121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nouchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsukada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marumo</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis</article-title>
<source/>Liver
          <year>1991</year>
<volume>11</volume>
<fpage>100</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">2051901</pub-id>
</element-citation>
</ref>
<ref id="R122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imaeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ohkubo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Musha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Komachi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakazato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats</article-title>
<source/>J Radiat Res
          <year>2014</year>
<volume>55</volume>
<fpage>665</fpage>
<lpage>73</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jrr/rru005">https://doi.org/10.1093/jrr/rru005</ext-link>
</comment>
<pub-id pub-id-type="pmid">24566720</pub-id>
</element-citation>
</ref>
<ref id="R123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chaponnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hüttner</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing</article-title>
<source/>J Cell Biol
          <year>1978</year>
<volume>76</volume>
<fpage>561</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">564911</pub-id>
</element-citation>
</ref>
<ref id="R124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bochaton-Piallat</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Ropraz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Geinoz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Borsi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zardi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1</article-title>
<source/>J Cell Biol
          <year>1998</year>
<volume>142</volume>
<fpage>873</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">9700173</pub-id>
</element-citation>
</ref>
<ref id="R125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desmoulière</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Redard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Darby</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar</article-title>
<source/>Am J Pathol
          <year>1995</year>
<volume>146</volume>
<fpage>56</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="pmid">7856739</pub-id>
</element-citation>
</ref>
<ref id="R126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van De Water</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Varney</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tomasek</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention</article-title>
<source/>Adv Wound Care
          <year>2013</year>
<volume>2</volume>
<fpage>122</fpage>
<lpage>41</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/wound.2012.0393">https://doi.org/10.1089/wound.2012.0393</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Camenzind</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bacchetta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Virmani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bochaton-Piallat</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion</article-title>
<source/>Arterioscler Thromb Vasc Biol
          <year>2006</year>
<volume>26</volume>
<fpage>326</fpage>
<lpage>32</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.ATV.0000199393.74656.4c">https://doi.org/10.1161/01.ATV.0000199393.74656.4c</ext-link>
</comment>
<pub-id pub-id-type="pmid">16339500</pub-id>
</element-citation>
</ref>
<ref id="R128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Evolving challenges in hepatic fibrosis</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2010</year>
<volume>7</volume>
<fpage>425</fpage>
<lpage>36</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrgastro.2010.97">https://doi.org/10.1038/nrgastro.2010.97</ext-link>
</comment>
<pub-id pub-id-type="pmid">20585339</pub-id>
</element-citation>
</ref>
<ref id="R129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffield</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Cellular and molecular mechanisms in kidney fibrosis</article-title>
<source/>J Clin Invest
          <year>2014</year>
<volume>124</volume>
<fpage>2299</fpage>
<lpage>306</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI72267">https://doi.org/10.1172/JCI72267</ext-link>
</comment>
<pub-id pub-id-type="pmid">24892703</pub-id>
</element-citation>
</ref>
<ref id="R130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galligan</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Fish</surname>
<given-names>EN</given-names>
</name>
</person-group>
<article-title>The role of circulating fibrocytes in inflammation and autoimmunity</article-title>
<source/>J Leukoc Biol
          <year>2013</year>
<volume>93</volume>
<fpage>45</fpage>
<lpage>50</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1189/jlb.0712365">https://doi.org/10.1189/jlb.0712365</ext-link>
</comment>
<pub-id pub-id-type="pmid">22993208</pub-id>
</element-citation>
</ref>
<ref id="R131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiavegato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bochaton-Piallat</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>D’Amore</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sartore</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia</article-title>
<source/>Virchows Arch Int J Pathol
          <year>1995</year>
<volume>426</volume>
<fpage>77</fpage>
<lpage>86</lpage>
</element-citation>
</ref>
<ref id="R132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kendall</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Feghali-Bostwick</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Fibroblasts in fibrosis: novel roles and mediators</article-title>
<source/>Front Pharmacol
          <year>2014</year>
<volume>5</volume>
<fpage>123</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2014.00123">https://doi.org/10.3389/fphar.2014.00123</ext-link>
</comment>
<pub-id pub-id-type="pmid">24904424</pub-id>
</element-citation>
</ref>
<ref id="R133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pasche</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Transforming growth factor beta as a therapeutic target in systemic sclerosis</article-title>
<source/>Nat Rev Rheumatol
          <year>2009</year>
<volume>5</volume>
<fpage>200</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrrheum.2009.26">https://doi.org/10.1038/nrrheum.2009.26</ext-link>
</comment>
<pub-id pub-id-type="pmid">19337284</pub-id>
</element-citation>
</ref>
<ref id="R134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tourtellotte</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy</article-title>
<source/>Autoimmun Rev
          <year>2011</year>
<volume>10</volume>
<fpage>267</fpage>
<lpage>75</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.autrev.2010.09.015">https://doi.org/10.1016/j.autrev.2010.09.015</ext-link>
</comment>
<pub-id pub-id-type="pmid">20863909</pub-id>
</element-citation>
</ref>
<ref id="R135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Kugler</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Wolters</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Robillard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Galvez</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Brumwell</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Sheppard</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Alveolar epithelial cell mesenchymal transition develops <italic>in vivo</italic> during pulmonary fibrosis and is regulated by the extracellular matrix</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2006</year>
<volume>103</volume>
<fpage>13180</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0605669103">https://doi.org/10.1073/pnas.0605669103</ext-link>
</comment>
<pub-id pub-id-type="pmid">16924102</pub-id>
</element-citation>
</ref>
<ref id="R136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goffin</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Pittet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Csucs</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lussi</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Meister</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers</article-title>
<source/>J Cell Biol
          <year>2006</year>
<volume>172</volume>
<fpage>259</fpage>
<lpage>68</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.200506179">https://doi.org/10.1083/jcb.200506179</ext-link>
</comment>
<pub-id pub-id-type="pmid">16401722</pub-id>
</element-citation>
</ref>
<ref id="R137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desmoulière</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Geinoz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts</article-title>
<source/>J Cell Biol
          <year>1993</year>
<volume>122</volume>
<fpage>103</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">8314838</pub-id>
</element-citation>
</ref>
<ref id="R138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Celetta</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tomasek</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chaponnier</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Alpha-smooth muscle actin expression upregulates fibroblast contractile activity</article-title>
<source/>Mol Biol Cell
          <year>2001</year>
<volume>12</volume>
<fpage>2730</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">11553712</pub-id>
</element-citation>
</ref>
<ref id="R139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dugina</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fontao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chaponnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vasiliev</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors</article-title>
<source/>J Cell Sci
          <year>2001</year>
<volume>114</volume>
<fpage>3285</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">11591817</pub-id>
</element-citation>
</ref>
<ref id="R140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conti</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Adelstein</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Nonmuscle myosin II moves in new directions</article-title>
<source/>J Cell Sci
          <year>2008</year>
<volume>121</volume>
<fpage>11</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jcs.007112">https://doi.org/10.1242/jcs.007112</ext-link>
</comment>
<pub-id pub-id-type="pmid">18096687</pub-id>
</element-citation>
</ref>
<ref id="R141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Timbely</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Arsalane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moumen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guerin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guizard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Role of both actin-myosin cross bridges and NO-cGMP pathway modulators in the contraction and relaxation of human placental stem villi</article-title>
<source/>Placenta
          <year>2013</year>
<volume>34</volume>
<fpage>1163</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.placenta.2013.10.007">https://doi.org/10.1016/j.placenta.2013.10.007</ext-link>
</comment>
<pub-id pub-id-type="pmid">24183754</pub-id>
</element-citation>
</ref>
<ref id="R142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shinomiya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fujitani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Key</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ohashi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Biochemical and immunohistochemical characterization of the isoforms of myosin and actin in human placenta</article-title>
<source/>Placenta
          <year>2011</year>
<volume>32</volume>
<fpage>347</fpage>
<lpage>55</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.placenta.2011.02.008">https://doi.org/10.1016/j.placenta.2011.02.008</ext-link>
</comment>
<pub-id pub-id-type="pmid">21420731</pub-id>
</element-citation>
</ref>
<ref id="R143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parizi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Tomasek</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase</article-title>
<source/>Exp Cell Res
          <year>2000</year>
<volume>254</volume>
<fpage>210</fpage>
<lpage>20</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1006/excr.1999.4754">https://doi.org/10.1006/excr.1999.4754</ext-link>
</comment>
<pub-id pub-id-type="pmid">10640419</pub-id>
</element-citation>
</ref>
<ref id="R144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomasek</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Vaughan</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Kropp</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Haaksma</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity</article-title>
<source/>Wound Repair Regen
          <year>2006</year>
<volume>14</volume>
<fpage>313</fpage>
<lpage>20</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1743-6109.2006.00126.x">https://doi.org/10.1111/j.1743-6109.2006.00126.x</ext-link>
</comment>
<pub-id pub-id-type="pmid">16808810</pub-id>
</element-citation>
</ref>
<ref id="R145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovács</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sellers</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Functional divergence of human cytoplasmic myosin II: kinetic characterization of the non-muscle IIA isoform</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<fpage>38132</fpage>
<lpage>40</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M305453200">https://doi.org/10.1074/jbc.M305453200</ext-link>
</comment>
<pub-id pub-id-type="pmid">12847096</pub-id>
</element-citation>
</ref>
<ref id="R146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guerin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Arsalane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moumen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Krokidis</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Timbely</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Ultraslow myosin molecular motors of placental contractile stem villi in humans</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e108814</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0108814">https://doi.org/10.1371/journal.pone.0108814</ext-link>
</comment>
<pub-id pub-id-type="pmid">25268142</pub-id>
</element-citation>
</ref>
<ref id="R147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Krokidis</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Timbely</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Statistical mechanics of the human placenta: a stationary state of a near-equilibrium system in a linear regime</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<fpage>e0142471</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0142471">https://doi.org/10.1371/journal.pone.0142471</ext-link>
</comment>
<pub-id pub-id-type="pmid">26569482</pub-id>
</element-citation>
</ref>
<ref id="R148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farley</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>GN</given-names>
</name>
</person-group>
<article-title>Contractile properties of human placental anchoring villi</article-title>
<source/>Am J Physiol Regul Integr Comp Physiol
          <year>2004</year>
<volume>287</volume>
<fpage>R680</fpage>
<lpage>685</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpregu.00222.2004">https://doi.org/10.1152/ajpregu.00222.2004</ext-link>
</comment>
<pub-id pub-id-type="pmid">15142834</pub-id>
</element-citation>
</ref>
<ref id="R149">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huszar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Isolation and characterization of myosin in the human term placenta</article-title>
<source/>Am J Obstet Gynecol
          <year>1979</year>
<volume>135</volume>
<fpage>707</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">158981</pub-id>
</element-citation>
</ref>
<ref id="R150">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Actomyosin content of the human placenta</article-title>
<source/>J Obstet Gynaecol Br Commonw
          <year>1974</year>
<volume>81</volume>
<fpage>307</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">4824689</pub-id>
</element-citation>
</ref>
<ref id="R151">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Amerongen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Towards an integrated view of Wnt signaling in development</article-title>
<source/>Development
          <year>2009</year>
<volume>136</volume>
<fpage>3205</fpage>
<lpage>14</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.033910">https://doi.org/10.1242/dev.033910</ext-link>
</comment>
<pub-id pub-id-type="pmid">19736321</pub-id>
</element-citation>
</ref>
<ref id="R152">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Harthi</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders</article-title>
<source/>J Neuroimmune Pharmacol
          <year>2012</year>
<volume>7</volume>
<fpage>725</fpage>
<lpage>30</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11481-012-9412-x">https://doi.org/10.1007/s11481-012-9412-x</ext-link>
</comment>
<pub-id pub-id-type="pmid">23114888</pub-id>
</element-citation>
</ref>
<ref id="R153">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Logan</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The Wnt signaling pathway in development and disease</article-title>
<source/>Annu Rev Cell Dev Biol
          <year>2004</year>
<volume>20</volume>
<fpage>781</fpage>
<lpage>810</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.cellbio.20.010403.113126">https://doi.org/10.1146/annurev.cellbio.20.010403.113126</ext-link>
</comment>
<pub-id pub-id-type="pmid">15473860</pub-id>
</element-citation>
</ref>
<ref id="R154">
<label>154</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>Proximal events in Wnt signal transduction</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2009</year>
<volume>10</volume>
<fpage>468</fpage>
<lpage>77</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrm2717">https://doi.org/10.1038/nrm2717</ext-link>
</comment>
<pub-id pub-id-type="pmid">19536106</pub-id>
</element-citation>
</ref>
<ref id="R155">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clevers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling and disease</article-title>
<source/>Cell
          <year>2012</year>
<volume>149</volume>
<fpage>1192</fpage>
<lpage>205</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2012.05.012">https://doi.org/10.1016/j.cell.2012.05.012</ext-link>
</comment>
<pub-id pub-id-type="pmid">22682243</pub-id>
</element-citation>
</ref>
<ref id="R156">
<label>156</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aberle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stappert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kispert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kemler</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>β-catenin is a target for the ubiquitin–proteasome pathway</article-title>
<source/>EMBO J
          <year>1997</year>
<volume>16</volume>
<fpage>3797</fpage>
<lpage>804</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/emboj/16.13.3797">https://doi.org/10.1093/emboj/16.13.3797</ext-link>
</comment>
<pub-id pub-id-type="pmid">9233789</pub-id>
</element-citation>
</ref>
<ref id="R157">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurung</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Alman</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Beta-catenin is a mediator of the response of fibroblasts to irradiation</article-title>
<source/>Am J Pathol
          <year>2009</year>
<volume>174</volume>
<fpage>248</fpage>
<lpage>55</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2009.080576">https://doi.org/10.2353/ajpath.2009.080576</ext-link>
</comment>
<pub-id pub-id-type="pmid">19036807</pub-id>
</element-citation>
</ref>
<ref id="R158">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Roh</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SY</given-names>
</name>
</person-group>
<article-title>Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer</article-title>
<source/>Int J Cancer
          <year>2008</year>
<volume>122</volume>
<fpage>100</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.23069">https://doi.org/10.1002/ijc.23069</ext-link>
</comment>
<pub-id pub-id-type="pmid">17764107</pub-id>
</element-citation>
</ref>
<ref id="R159">
<label>159</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Woodward</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Behbod</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Peddibhotla</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alfaro</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Buchholz</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line</article-title>
<source/>J Cell Sci
          <year>2007</year>
<volume>120</volume>
<fpage>468</fpage>
<lpage>77</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jcs.03348">https://doi.org/10.1242/jcs.03348</ext-link>
</comment>
<pub-id pub-id-type="pmid">17227796</pub-id>
</element-citation>
</ref>
<ref id="R160">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Sok</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BY</given-names>
</name>
</person-group>
<article-title>Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts</article-title>
<source/>Cell Signal
          <year>2008</year>
<volume>20</volume>
<fpage>602</fpage>
<lpage>12</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cellsig.2007.10.022">https://doi.org/10.1016/j.cellsig.2007.10.022</ext-link>
</comment>
<pub-id pub-id-type="pmid">18243662</pub-id>
</element-citation>
</ref>
<ref id="R161">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rødningen</surname>
<given-names>OK</given-names>
</name>
<name>
<surname>Overgaard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alsner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hastie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Børresen-Dale</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts</article-title>
<source/>Radiother Oncol
          <year>2005</year>
<volume>77</volume>
<fpage>231</fpage>
<lpage>40</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.radonc.2005.09.020">https://doi.org/10.1016/j.radonc.2005.09.020</ext-link>
</comment>
<pub-id pub-id-type="pmid">16297999</pub-id>
</element-citation>
</ref>
<ref id="R162">
<label>162</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aumiller</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Balsara</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wilhelm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Günther</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Königshoff</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis</article-title>
<source/>Am J Respir Cell Mol Biol
          <year>2013</year>
<volume>49</volume>
<fpage>96</fpage>
<lpage>104</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1165/rcmb.2012-0524OC">https://doi.org/10.1165/rcmb.2012-0524OC</ext-link>
</comment>
<pub-id pub-id-type="pmid">23526221</pub-id>
</element-citation>
</ref>
<ref id="R163">
<label>163</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baarsma</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Spanjer</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Haitsma</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Engelbertink</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Meurs</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jonker</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Timens</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Postma</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Kerstjens</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Gosens</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β1 is increased in chronic obstructive pulmonary disease</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e25450</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0025450">https://doi.org/10.1371/journal.pone.0025450</ext-link>
</comment>
<pub-id pub-id-type="pmid">21980461</pub-id>
</element-citation>
</ref>
<ref id="R164">
<label>164</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dees</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Distler</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?</article-title>
<source/>Exp Dermatol
          <year>2013</year>
<volume>22</volume>
<fpage>710</fpage>
<lpage>3</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/exd.12255">https://doi.org/10.1111/exd.12255</ext-link>
</comment>
<pub-id pub-id-type="pmid">24118232</pub-id>
</element-citation>
</ref>
<ref id="R165">
<label>165</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Königshoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kneidinger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Eickelberg</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen</article-title>
<source/>Swiss Med Wkly
          <year>2009</year>
<volume>139</volume>
<fpage>554</fpage>
<lpage>63</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/smw-12528">https://doi.org/smw-12528</ext-link>
</comment>
<pub-id pub-id-type="pmid">19838873</pub-id>
</element-citation>
</ref>
<ref id="R166">
<label>166</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Königshoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eickelberg</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>WNT signaling in lung disease: a failure or a regeneration signal?</article-title>
<source/>Am J Respir Cell Mol Biol
          <year>2010</year>
<volume>42</volume>
<fpage>21</fpage>
<lpage>31</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1165/rcmb.2008-0485TR">https://doi.org/10.1165/rcmb.2008-0485TR</ext-link>
</comment>
<pub-id pub-id-type="pmid">19329555</pub-id>
</element-citation>
</ref>
<ref id="R167">
<label>167</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Sargent</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hamburg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hinchcliff</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gottardi</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Atit</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Whitfield</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells</article-title>
<source/>Arthritis Rheum
          <year>2012</year>
<volume>64</volume>
<fpage>2734</fpage>
<lpage>45</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.34424">https://doi.org/10.1002/art.34424</ext-link>
</comment>
<pub-id pub-id-type="pmid">22328118</pub-id>
</element-citation>
</ref>
<ref id="R168">
<label>168</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brazil</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Hemmings</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Advances in protein kinase B signalling: AKTion on multiple fronts</article-title>
<source/>Trends Biochem Sci
          <year>2004</year>
<volume>29</volume>
<fpage>233</fpage>
<lpage>42</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tibs.2004.03.006">https://doi.org/10.1016/j.tibs.2004.03.006</ext-link>
</comment>
<pub-id pub-id-type="pmid">15130559</pub-id>
</element-citation>
</ref>
<ref id="R169">
<label>169</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciuffreda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Di Sanza</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Incani</surname>
<given-names>UC</given-names>
</name>
<name>
<surname>Milella</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The mTOR pathway: a new target in cancer therapy</article-title>
<source/>Curr Cancer Drug Targets
          <year>2010</year>
<volume>10</volume>
<fpage>484</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">20384580</pub-id>
</element-citation>
</ref>
<ref id="R170">
<label>170</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heras-Sandoval</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pérez-Rojas</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hernández-Damián</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pedraza-Chaverri</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</article-title>
<source/>Cell Signal
          <year>2014</year>
<volume>26</volume>
<fpage>2694</fpage>
<lpage>701</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cellsig.2014.08.019">https://doi.org/10.1016/j.cellsig.2014.08.019</ext-link>
</comment>
<pub-id pub-id-type="pmid">25173700</pub-id>
</element-citation>
</ref>
<ref id="R171">
<label>171</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination</article-title>
<source/>Development
          <year>2016</year>
<volume>143</volume>
<fpage>3050</fpage>
<lpage>60</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.137075">https://doi.org/10.1242/dev.137075</ext-link>
</comment>
<pub-id pub-id-type="pmid">27578176</pub-id>
</element-citation>
</ref>
<ref id="R172">
<label>172</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alberts</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders</article-title>
<source/>Int J Dev Neurosci
          <year>2014</year>
<volume>35</volume>
<fpage>35</fpage>
<lpage>41</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijdevneu.2014.03.006">https://doi.org/10.1016/j.ijdevneu.2014.03.006</ext-link>
</comment>
<pub-id pub-id-type="pmid">24662006</pub-id>
</element-citation>
</ref>
<ref id="R173">
<label>173</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nguyen-McCarty</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hexner</surname>
<given-names>EO</given-names>
</name>
<name>
<surname>Danet-Desnoyers</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways</article-title>
<source/>Nat Med
          <year>2012</year>
<volume>18</volume>
<fpage>1778</fpage>
<lpage>85</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.2984">https://doi.org/10.1038/nm.2984</ext-link>
</comment>
<pub-id pub-id-type="pmid">23142822</pub-id>
</element-citation>
</ref>
<ref id="R174">
<label>174</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>YP</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>YW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway</article-title>
<source/>Exp Cell Res
          <year>2004</year>
<volume>297</volume>
<fpage>424</fpage>
<lpage>33</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.yexcr.2004.03.034">https://doi.org/10.1016/j.yexcr.2004.03.034</ext-link>
</comment>
<pub-id pub-id-type="pmid">15212945</pub-id>
</element-citation>
</ref>
<ref id="R175">
<label>175</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1366</volume>
<fpage>27</fpage>
<lpage>37</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.brainres.2010.10.032">https://doi.org/10.1016/j.brainres.2010.10.032</ext-link>
</comment>
<pub-id pub-id-type="pmid">20969832</pub-id>
</element-citation>
</ref>
<ref id="R176">
<label>176</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Hemati</surname>
<given-names>N</given-names>
</name>
<name>
<surname>MacDougald</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase</article-title>
<source/>Mol Cell Biol
          <year>1999</year>
<volume>19</volume>
<fpage>8433</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">10567568</pub-id>
</element-citation>
</ref>
<ref id="R177">
<label>177</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>QQ</given-names>
</name>
<name>
<surname>Grønborg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Otto</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2005</year>
<volume>102</volume>
<fpage>9766</fpage>
<lpage>71</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0503891102">https://doi.org/10.1073/pnas.0503891102</ext-link>
</comment>
<pub-id pub-id-type="pmid">15985551</pub-id>
</element-citation>
</ref>
<ref id="R178">
<label>178</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>NF-kappaB as a critical link between inflammation and cancer</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2009</year>
<volume>1</volume>
<fpage>a000141</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a000141">https://doi.org/10.1101/cshperspect.a000141</ext-link>
</comment>
<pub-id pub-id-type="pmid">20066113</pub-id>
</element-citation>
</ref>
<ref id="R179">
<label>179</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasparakis</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases</article-title>
<source/>Nat Rev Immunol
          <year>2009</year>
<volume>9</volume>
<fpage>778</fpage>
<lpage>88</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nri2655">https://doi.org/10.1038/nri2655</ext-link>
</comment>
<pub-id pub-id-type="pmid">19855404</pub-id>
</element-citation>
</ref>
<ref id="R180">
<label>180</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Neriah</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Inflammation meets cancer, with NF-κB as the matchmaker</article-title>
<source/>Nat Immunol
          <year>2011</year>
<volume>12</volume>
<fpage>715</fpage>
<lpage>23</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ni.2060">https://doi.org/10.1038/ni.2060</ext-link>
</comment>
<pub-id pub-id-type="pmid">21772280</pub-id>
</element-citation>
</ref>
<ref id="R181">
<label>181</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tak</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>NF-kappaB: a key role in inflammatory diseases</article-title>
<source/>J Clin Invest
          <year>2001</year>
<volume>107</volume>
<fpage>7</fpage>
<lpage>11</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI11830">https://doi.org/10.1172/JCI11830</ext-link>
</comment>
<pub-id pub-id-type="pmid">11134171</pub-id>
</element-citation>
</ref>
<ref id="R182">
<label>182</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hottiger</surname>
<given-names>MO</given-names>
</name>
</person-group>
<article-title>Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation</article-title>
<source/>Front Immunol
          <year>2016</year>
<volume>7</volume>
<fpage>378</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2016.00378">https://doi.org/10.3389/fimmu.2016.00378</ext-link>
</comment>
<pub-id pub-id-type="pmid">27713747</pub-id>
</element-citation>
</ref>
<ref id="R183">
<label>183</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oguma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Uchio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Naka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hirao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saya</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taketo</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells</article-title>
<source/>EMBO J
          <year>2008</year>
<volume>27</volume>
<fpage>1671</fpage>
<lpage>81</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/emboj.2008.105">https://doi.org/10.1038/emboj.2008.105</ext-link>
</comment>
<pub-id pub-id-type="pmid">18511911</pub-id>
</element-citation>
</ref>
<ref id="R184">
<label>184</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tomann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Andl</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gallant</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Huelsken</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jerchow</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Birchmeier</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Paus</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mikkola</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Morrisey</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Overbeek</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Scheidereit</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction</article-title>
<source/>Dev Cell
          <year>2009</year>
<volume>17</volume>
<fpage>49</fpage>
<lpage>61</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.devcel.2009.05.011">https://doi.org/10.1016/j.devcel.2009.05.011</ext-link>
</comment>
<pub-id pub-id-type="pmid">19619491</pub-id>
</element-citation>
</ref>
<ref id="R185">
<label>185</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nejak-Bowen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Monga</surname>
<given-names>SPS</given-names>
</name>
</person-group>
<article-title>Beta-catenin-NF-κB interactions in murine hepatocytes: a complex to die for</article-title>
<source/>Hepatology
          <year>2013</year>
<volume>57</volume>
<fpage>763</fpage>
<lpage>74</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/hep.26042">https://doi.org/10.1002/hep.26042</ext-link>
</comment>
<pub-id pub-id-type="pmid">22941935</pub-id>
</element-citation>
</ref>
<ref id="R186">
<label>186</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spiegelman</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Slaga</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Pagano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Minamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ronai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>SY</given-names>
</name>
</person-group>
<article-title>Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor</article-title>
<source/>Mol Cell
          <year>2000</year>
<volume>5</volume>
<fpage>877</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">10882123</pub-id>
</element-citation>
</ref>
<ref id="R187">
<label>187</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noubissi</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Elcheva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shakoori</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ougolkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Minamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>VS</given-names>
</name>
</person-group>
<article-title>CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling</article-title>
<source/>Nature
          <year>2006</year>
<volume>441</volume>
<fpage>898</fpage>
<lpage>901</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature04839">https://doi.org/10.1038/nature04839</ext-link>
</comment>
<pub-id pub-id-type="pmid">16778892</pub-id>
</element-citation>
</ref>
<ref id="R188">
<label>188</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuphal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Poser</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jobin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hellerbrand</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bosserhoff</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma</article-title>
<source/>Oncogene
          <year>2004</year>
<volume>23</volume>
<fpage>8509</fpage>
<lpage>19</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1207831">https://doi.org/10.1038/sj.onc.1207831</ext-link>
</comment>
<pub-id pub-id-type="pmid">15378016</pub-id>
</element-citation>
</ref>
<ref id="R189">
<label>189</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crain-Denoyelle</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Baud</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chereau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gougelet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Terris</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yamagoe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Colnot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Viguier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perret</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Couty</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice</article-title>
<source/>J Clin Invest
          <year>2012</year>
<volume>122</volume>
<fpage>586</fpage>
<lpage>99</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI43937">https://doi.org/10.1172/JCI43937</ext-link>
</comment>
<pub-id pub-id-type="pmid">22251704</pub-id>
</element-citation>
</ref>
<ref id="R190">
<label>190</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Adhikari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>The role of [beta]-transducin repeat-containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells</article-title>
<source/>Arterioscler Thromb Vasc Biol
          <year>2004</year>
<volume>24</volume>
<fpage>85</fpage>
<lpage>90</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.ATV.0000104012.40720.c4">https://doi.org/10.1161/01.ATV.0000104012.40720.c4</ext-link>
</comment>
<pub-id pub-id-type="pmid">14592850</pub-id>
</element-citation>
</ref>
<ref id="R191">
<label>191</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schön</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Flierman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ofner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stahringer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Holdt</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Kolligs</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Herbst</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>β-catenin regulates NF-κB activity via TNFRSF19 in colorectal cancer cells</article-title>
<source/>Int J Cancer
          <year>2014</year>
<volume>135</volume>
<fpage>1800</fpage>
<lpage>11</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.28839">https://doi.org/10.1002/ijc.28839</ext-link>
</comment>
<pub-id pub-id-type="pmid">24623448</pub-id>
</element-citation>
</ref>
<ref id="R192">
<label>192</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Wnt1 participates in inflammation induced by lipopolysaccharide through upregulating scavenger receptor A and NF-kB</article-title>
<source/>Inflammation
          <year>2015</year>
<volume>38</volume>
<fpage>1700</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10753-015-0147-8">https://doi.org/10.1007/s10753-015-0147-8</ext-link>
</comment>
<pub-id pub-id-type="pmid">25749569</pub-id>
</element-citation>
</ref>
<ref id="R193">
<label>193</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Beta-catenin binds to the downstream region and regulates the expression C-reactive protein gene</article-title>
<source/>Nucleic Acids Res
          <year>2007</year>
<volume>35</volume>
<fpage>5511</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkm547">https://doi.org/10.1093/nar/gkm547</ext-link>
</comment>
<pub-id pub-id-type="pmid">17704137</pub-id>
</element-citation>
</ref>
<ref id="R194">
<label>194</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>K</given-names>
</name>
<name>
<surname>So</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Jash</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Lymphoid enhancer binding factor 1 regulates transcription through gene looping</article-title>
<source/>J Immunol
          <year>2009</year>
<volume>183</volume>
<fpage>5129</fpage>
<lpage>37</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.0802744">https://doi.org/10.4049/jimmunol.0802744</ext-link>
</comment>
<pub-id pub-id-type="pmid">19783677</pub-id>
</element-citation>
</ref>
<ref id="R195">
<label>195</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Post</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Karperien</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>T cell factor 4 is a pro-catabolic and apoptotic factor in human articular chondrocytes by potentiating nuclear factor κB signaling</article-title>
<source/>J Biol Chem
          <year>2013</year>
<volume>288</volume>
<fpage>17552</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M113.453985">https://doi.org/10.1074/jbc.M113.453985</ext-link>
</comment>
<pub-id pub-id-type="pmid">23603903</pub-id>
</element-citation>
</ref>
<ref id="R196">
<label>196</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Filion</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Figeys</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer</article-title>
<source/>Cell Death Differ
          <year>2015</year>
<volume>22</volume>
<fpage>298</fpage>
<lpage>310</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cdd.2014.145">https://doi.org/10.1038/cdd.2014.145</ext-link>
</comment>
<pub-id pub-id-type="pmid">25257174</pub-id>
</element-citation>
</ref>
<ref id="R197">
<label>197</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummins</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Berra</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Comerford</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Ginouves</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Seeballuck</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Godson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Moynagh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pouyssegur</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>CT</given-names>
</name>
</person-group>
<article-title>Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2006</year>
<volume>103</volume>
<fpage>18154</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0602235103">https://doi.org/10.1073/pnas.0602235103</ext-link>
</comment>
<pub-id pub-id-type="pmid">17114296</pub-id>
</element-citation>
</ref>
<ref id="R198">
<label>198</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholz</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Cavadas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Tambuwala</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Hams</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rodríguez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>von Kriegsheim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bruning</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Fallon</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cummins</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>CT</given-names>
</name>
</person-group>
<article-title>Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<fpage>18490</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1309718110">https://doi.org/10.1073/pnas.1309718110</ext-link>
</comment>
<pub-id pub-id-type="pmid">24145445</pub-id>
</element-citation>
</ref>
<ref id="R199">
<label>199</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buss</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dörrie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Livingstone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Resch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kracht</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<fpage>49571</fpage>
<lpage>4</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.C400442200">https://doi.org/10.1074/jbc.C400442200</ext-link>
</comment>
<pub-id pub-id-type="pmid">15465828</pub-id>
</element-citation>
</ref>
<ref id="R200">
<label>200</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saegusa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashimura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuwata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hamano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okayasu</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells</article-title>
<source/>J Pathol
          <year>2007</year>
<volume>213</volume>
<fpage>35</fpage>
<lpage>45</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/path.2198">https://doi.org/10.1002/path.2198</ext-link>
</comment>
<pub-id pub-id-type="pmid">17607667</pub-id>
</element-citation>
</ref>
<ref id="R201">
<label>201</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamberti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Byers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>Regulation of beta-catenin function by the IkappaB kinases</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<fpage>42276</fpage>
<lpage>86</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M104227200">https://doi.org/10.1074/jbc.M104227200</ext-link>
</comment>
<pub-id pub-id-type="pmid">11527961</pub-id>
</element-citation>
</ref>
<ref id="R202">
<label>202</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YD</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>NF-kappaB regulates Lef1 gene expression in chondrocytes</article-title>
<source/>Biochem Biophys Res Commun
          <year>2007</year>
<volume>357</volume>
<fpage>589</fpage>
<lpage>95</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2007.03.170">https://doi.org/10.1016/j.bbrc.2007.03.170</ext-link>
</comment>
<pub-id pub-id-type="pmid">17445771</pub-id>
</element-citation>
</ref>
<ref id="R203">
<label>203</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Crossregulation of beta-catenin/Tcf pathway by NF-kappaB is mediated by lzts2 in human adipose tissue-derived mesenchymal stem cells</article-title>
<source/>Biochim Biophys Acta
          <year>2008</year>
<volume>1783</volume>
<fpage>419</fpage>
<lpage>28</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbamcr.2007.08.005">https://doi.org/10.1016/j.bbamcr.2007.08.005</ext-link>
</comment>
<pub-id pub-id-type="pmid">17950943</pub-id>
</element-citation>
</ref>
<ref id="R204">
<label>204</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells</article-title>
<source/>FEBS Lett
          <year>2008</year>
<volume>582</volume>
<fpage>616</fpage>
<lpage>22</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.febslet.2008.01.029">https://doi.org/10.1016/j.febslet.2008.01.029</ext-link>
</comment>
<pub-id pub-id-type="pmid">18242184</pub-id>
</element-citation>
</ref>
<ref id="R205">
<label>205</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albanese</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>D’Amico</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jarrett</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Joyce</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hulit</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sakamaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ben-Ze’ev</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Lamberti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf</article-title>
<source/>Mol Biol Cell
          <year>2003</year>
<volume>14</volume>
<fpage>585</fpage>
<lpage>99</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1091/mbc.02-06-0101">https://doi.org/10.1091/mbc.02-06-0101</ext-link>
</comment>
<pub-id pub-id-type="pmid">12589056</pub-id>
</element-citation>
</ref>
<ref id="R206">
<label>206</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Beisswenger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Herr</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hellberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zakharkina</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Voss</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wiewrodt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bohle</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Menger</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Stöckel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lenhof</surname>
<given-names>HP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/β-catenin signaling in murine and human tumor cells</article-title>
<source/>Oncogene
          <year>2014</year>
<volume>33</volume>
<fpage>1239</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2013.75">https://doi.org/10.1038/onc.2013.75</ext-link>
</comment>
<pub-id pub-id-type="pmid">23563178</pub-id>
</element-citation>
</ref>
<ref id="R207">
<label>207</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>NF-kappa B-mediated adaptive resistance to ionizing radiation</article-title>
<source/>Free Radic Biol Med
          <year>2008</year>
<volume>44</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2007.09.022">https://doi.org/10.1016/j.freeradbiomed.2007.09.022</ext-link>
</comment>
<pub-id pub-id-type="pmid">17967430</pub-id>
</element-citation>
</ref>
<ref id="R208">
<label>208</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chou</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Radiation-induced interleukin-6 expression through MAPK/p38/NF-kappaB signaling pathway and the resultant antiapoptotic effect on endothelial cells through Mcl-1 expression with sIL6-Ralpha</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2009</year>
<volume>75</volume>
<fpage>1553</fpage>
<lpage>61</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2009.08.034">https://doi.org/10.1016/j.ijrobp.2009.08.034</ext-link>
</comment>
<pub-id pub-id-type="pmid">19931737</pub-id>
</element-citation>
</ref>
<ref id="R209">
<label>209</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>ZF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB</article-title>
<source/>World J Gastroenterol
          <year>2012</year>
<volume>18</volume>
<fpage>1680</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3748/wjg.v18.i14.1680">https://doi.org/10.3748/wjg.v18.i14.1680</ext-link>
</comment>
<pub-id pub-id-type="pmid">22529699</pub-id>
</element-citation>
</ref>
<ref id="R210">
<label>210</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghildiyal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα</article-title>
<source/>Cell Death Dis
          <year>2013</year>
<volume>4</volume>
<fpage>e615</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cddis.2013.128">https://doi.org/10.1038/cddis.2013.128</ext-link>
</comment>
<pub-id pub-id-type="pmid">23640457</pub-id>
</element-citation>
</ref>
<ref id="R211">
<label>211</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colston</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>de la Rosa</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Koehler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mestril</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Chandrasekar</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor</article-title>
<source/>Am J Physiol Heart Circ Physiol
          <year>2007</year>
<volume>293</volume>
<fpage>H1839</fpage>
<lpage>46</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpheart.00428.2007">https://doi.org/10.1152/ajpheart.00428.2007</ext-link>
</comment>
<pub-id pub-id-type="pmid">17616748</pub-id>
</element-citation>
</ref>
<ref id="R212">
<label>212</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Königshoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Balsara</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wilhelm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Amarie</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Jahn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Seeger</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Günther</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eickelberg</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis</article-title>
<source/>J Clin Invest
          <year>2009</year>
<volume>119</volume>
<fpage>772</fpage>
<lpage>87</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI33950">https://doi.org/10.1172/JCI33950</ext-link>
</comment>
<pub-id pub-id-type="pmid">19287097</pub-id>
</element-citation>
</ref>
<ref id="R213">
<label>213</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desnoyers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Arnott</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pennica</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>WISP-1 binds to decorin and biglycan</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<fpage>47599</fpage>
<lpage>607</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M108339200">https://doi.org/10.1074/jbc.M108339200</ext-link>
</comment>
<pub-id pub-id-type="pmid">11598131</pub-id>
</element-citation>
</ref>
<ref id="R214">
<label>214</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Blockade of CCN4 attenuates CCl4-induced liver fibrosis</article-title>
<source/>Arch Med Sci
          <year>2015</year>
<volume>11</volume>
<fpage>647</fpage>
<lpage>53</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5114/aoms.2015.52371">https://doi.org/10.5114/aoms.2015.52371</ext-link>
</comment>
<pub-id pub-id-type="pmid">26170860</pub-id>
</element-citation>
</ref>
<ref id="R215">
<label>215</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blobe</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Schiemann</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Lodish</surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>Role of transforming growth factor beta in human disease</article-title>
<source/>N Engl J Med
          <year>2000</year>
<volume>342</volume>
<fpage>1350</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJM200005043421807">https://doi.org/10.1056/NEJM200005043421807</ext-link>
</comment>
<pub-id pub-id-type="pmid">10793168</pub-id>
</element-citation>
</ref>
<ref id="R216">
<label>216</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carthy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Garmaroudi</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>McManus</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>Wnt3a induces myofibroblast differentiation by upregulating TGF-β signaling through SMAD2 in a β-catenin-dependent manner</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e19809</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0019809">https://doi.org/10.1371/journal.pone.0019809</ext-link>
</comment>
<pub-id pub-id-type="pmid">21611174</pub-id>
</element-citation>
</ref>
<ref id="R217">
<label>217</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tourtellotte</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Hinchcliff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gottardi</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Fibrosis in systemic sclerosis: common and unique pathobiology</article-title>
<source/>Fibrogenesis Tissue Repair
          <year>2012</year>
<volume>5</volume>
<fpage>S18</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1755-1536-5-S1-S18">https://doi.org/10.1186/1755-1536-5-S1-S18</ext-link>
</comment>
<pub-id pub-id-type="pmid">23259815</pub-id>
</element-citation>
</ref>
<ref id="R218">
<label>218</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgescu</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>PTEN tumor suppressor network in PI3K-Akt pathway control</article-title>
<source/>Genes Cancer
          <year>2010</year>
<volume>1</volume>
<fpage>1170</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1947601911407325">https://doi.org/10.1177/1947601911407325</ext-link>
</comment>
<pub-id pub-id-type="pmid">21779440</pub-id>
</element-citation>
</ref>
<ref id="R219">
<label>219</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Atrasz</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Stambolic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Hogaboam</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Flaherty</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Kontos</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Toews</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)</article-title>
<source/>Am J Respir Crit Care Med
          <year>2006</year>
<volume>173</volume>
<fpage>112</fpage>
<lpage>21</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1164/rccm.200507-1058OC">https://doi.org/10.1164/rccm.200507-1058OC</ext-link>
</comment>
<pub-id pub-id-type="pmid">16179636</pub-id>
</element-citation>
</ref>
<ref id="R220">
<label>220</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Herazo-Maya</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Sennello</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Flozak</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mutlu</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Budinger</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>DasGupta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kaminski</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gottardi</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis</article-title>
<source/>Am J Respir Crit Care Med
          <year>2014</year>
<volume>190</volume>
<fpage>185</fpage>
<lpage>95</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1164/rccm.201401-0079OC">https://doi.org/10.1164/rccm.201401-0079OC</ext-link>
</comment>
<pub-id pub-id-type="pmid">24921217</pub-id>
</element-citation>
</ref>
<ref id="R221">
<label>221</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alarcón</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zaromytidou</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fujisawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barlas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Manova-Todorova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Macias</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sapkota</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Massagué</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways</article-title>
<source/>Cell
          <year>2009</year>
<volume>139</volume>
<fpage>757</fpage>
<lpage>69</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2009.09.035">https://doi.org/10.1016/j.cell.2009.09.035</ext-link>
</comment>
<pub-id pub-id-type="pmid">19914168</pub-id>
</element-citation>
</ref>
<ref id="R222">
<label>222</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhmetshina</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palumbo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dees</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Venalis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zerr</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kireva</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zwerina</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sadowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Riener</surname>
<given-names>MO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis</article-title>
<source/>Nat Commun
          <year>2012</year>
<volume>3</volume>
<fpage>735</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms1734">https://doi.org/10.1038/ncomms1734</ext-link>
</comment>
<pub-id pub-id-type="pmid">22415826</pub-id>
</element-citation>
</ref>
<ref id="R223">
<label>223</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuhashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miyazono</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway</article-title>
<source/>Mol Cell Biol
          <year>2001</year>
<volume>21</volume>
<fpage>5132</fpage>
<lpage>41</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.21.15.5132-5141.2001">https://doi.org/10.1128/MCB.21.15.5132-5141.2001</ext-link>
</comment>
<pub-id pub-id-type="pmid">11438668</pub-id>
</element-citation>
</ref>
<ref id="R224">
<label>224</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rui H Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia</article-title>
<source/>EMBO J
          <year>2006</year>
<volume>25</volume>
<fpage>1646</fpage>
<lpage>58</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.emboj.7601057">https://doi.org/10.1038/sj.emboj.7601057</ext-link>
</comment>
<pub-id pub-id-type="pmid">16601693</pub-id>
</element-citation>
</ref>
<ref id="R225">
<label>225</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Abdollah</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Grinnell</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Topper</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Gimbrone</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wrana</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Falb</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling</article-title>
<source/>Cell
          <year>1997</year>
<volume>89</volume>
<fpage>1165</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">9215638</pub-id>
</element-citation>
</ref>
<ref id="R226">
<label>226</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrigno</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lallemand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Verrecchia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>L’Hoste</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Camonis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Atfi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mauviel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling</article-title>
<source/>Oncogene
          <year>2002</year>
<volume>21</volume>
<fpage>4879</fpage>
<lpage>84</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1205623">https://doi.org/10.1038/sj.onc.1205623</ext-link>
</comment>
<pub-id pub-id-type="pmid">12118366</pub-id>
</element-citation>
</ref>
<ref id="R227">
<label>227</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>P</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoshimatsu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ten Dijke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>Smad7-induced beta-catenin degradation alters epidermal appendage development</article-title>
<source/>Dev Cell
          <year>2006</year>
<volume>11</volume>
<fpage>301</fpage>
<lpage>12</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.devcel.2006.06.014">https://doi.org/10.1016/j.devcel.2006.06.014</ext-link>
</comment>
<pub-id pub-id-type="pmid">16950122</pub-id>
</element-citation>
</ref>
<ref id="R228">
<label>228</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lagares</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Stopfer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marinković</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vrbanac</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Hiemer</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Sisson</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Horowitz</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Rosas</surname>
<given-names>IO</given-names>
</name>
<name>
<surname>Fredenburgh</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Feghali-Bostwick</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2015</year>
<volume>308</volume>
<fpage>L344</fpage>
<lpage>57</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajplung.00300.2014">https://doi.org/10.1152/ajplung.00300.2014</ext-link>
</comment>
<pub-id pub-id-type="pmid">25502501</pub-id>
</element-citation>
</ref>
<ref id="R229">
<label>229</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannaerts</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Verhulst</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Claerhout</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eysackers</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thoen</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Hoorens</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reynaert</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Halder</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van Grunsven</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>The Hippo pathway effector YAP controls mouse hepatic stellate cell activation</article-title>
<source/>J Hepatol
          <year>2015</year>
<volume>63</volume>
<fpage>679</fpage>
<lpage>88</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2015.04.011">https://doi.org/10.1016/j.jhep.2015.04.011</ext-link>
</comment>
<pub-id pub-id-type="pmid">25908270</pub-id>
</element-citation>
</ref>
<ref id="R230">
<label>230</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piersma</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bank</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Boersema</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Signaling in fibrosis: TGF-β, WNT, and YAP/TAZ converge</article-title>
<source/>Front Med (Lausanne)
          <year>2015</year>
<volume>2</volume>
<fpage>59</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2015.00059">https://doi.org/10.3389/fmed.2015.00059</ext-link>
</comment>
<pub-id pub-id-type="pmid">26389119</pub-id>
</element-citation>
</ref>
<ref id="R231">
<label>231</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varelas</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Samavarchi-Tehrani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Narimatsu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cockburn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Rossant</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wrana</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway</article-title>
<source/>Dev Cell
          <year>2010</year>
<volume>19</volume>
<fpage>831</fpage>
<lpage>44</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.devcel.2010.11.012">https://doi.org/10.1016/j.devcel.2010.11.012</ext-link>
</comment>
<pub-id pub-id-type="pmid">21145499</pub-id>
</element-citation>
</ref>
<ref id="R232">
<label>232</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imajo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyatake</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Iimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling</article-title>
<source/>EMBO J
          <year>2012</year>
<volume>31</volume>
<fpage>1109</fpage>
<lpage>22</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/emboj.2011.487">https://doi.org/10.1038/emboj.2011.487</ext-link>
</comment>
<pub-id pub-id-type="pmid">22234184</pub-id>
</element-citation>
</ref>
<ref id="R233">
<label>233</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varelas</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sakuma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Samavarchi-Tehrani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peerani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Dembowy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yaffe</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Zandstra</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Wrana</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal</article-title>
<source/>Nat Cell Biol
          <year>2008</year>
<volume>10</volume>
<fpage>837</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb1748">https://doi.org/10.1038/ncb1748</ext-link>
</comment>
<pub-id pub-id-type="pmid">18568018</pub-id>
</element-citation>
</ref>
<ref id="R234">
<label>234</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmadian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hah</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Liddle</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Atkins</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Downes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>PPARγ signaling and metabolism: the good, the bad and the future</article-title>
<source/>Nat Med
          <year>2013</year>
<volume>19</volume>
<fpage>557</fpage>
<lpage>66</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.3159">https://doi.org/10.1038/nm.3159</ext-link>
</comment>
<pub-id pub-id-type="pmid">23652116</pub-id>
</element-citation>
</ref>
<ref id="R235">
<label>235</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbrecht</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cullinan</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Leibowitz</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2</article-title>
<source/>Biochem Biophys Res Commun
          <year>1996</year>
<volume>224</volume>
<fpage>431</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">8702406</pub-id>
</element-citation>
</ref>
<ref id="R236">
<label>236</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fajas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Auboeuf</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Raspé</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schoonjans</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Saladin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Najib</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laville</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fruchart</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Deeb</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vidal-Puig</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Flier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Briggs</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The organization, promoter analysis, and expression of the human PPARgamma gene</article-title>
<source/>J Biol Chem
          <year>1997</year>
<volume>272</volume>
<fpage>18779</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">9228052</pub-id>
</element-citation>
</ref>
<ref id="R237">
<label>237</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricote</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Glass</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>PPARs and molecular mechanisms of transrepression</article-title>
<source/>Biochim Biophys Acta
          <year>2007</year>
<volume>1771</volume>
<fpage>926</fpage>
<lpage>35</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbalip.2007.02.013">https://doi.org/10.1016/j.bbalip.2007.02.013</ext-link>
</comment>
<pub-id pub-id-type="pmid">17433773</pub-id>
</element-citation>
</ref>
<ref id="R238">
<label>238</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakatos</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Thatcher</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Kottmann</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Phipps</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Sime</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>The role of PPARs in lung fibrosis</article-title>
<source/>PPAR Res
          <year>2007</year>
<volume>2007</volume>
<fpage>71323</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2007/71323">https://doi.org/10.1155/2007/71323</ext-link>
</comment>
<pub-id pub-id-type="pmid">17710235</pub-id>
</element-citation>
</ref>
<ref id="R239">
<label>239</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Joe</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jou</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<fpage>14747</fpage>
<lpage>52</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M210819200">https://doi.org/10.1074/jbc.M210819200</ext-link>
</comment>
<pub-id pub-id-type="pmid">12584205</pub-id>
</element-citation>
</ref>
<ref id="R240">
<label>240</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Daviaud</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pradère</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Grès</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guigné</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wabitsch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Valet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saulnier-Blache</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2</article-title>
<source/>J Biol Chem
          <year>2005</year>
<volume>280</volume>
<fpage>14656</fpage>
<lpage>62</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M412585200">https://doi.org/10.1074/jbc.M412585200</ext-link>
</comment>
<pub-id pub-id-type="pmid">15710620</pub-id>
</element-citation>
</ref>
<ref id="R241">
<label>241</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>McLennan</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Bonner</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Twigg</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Connective tissue growth factor inhibits adipocyte differentiation</article-title>
<source/>Am J Physiol Cell Physiol
          <year>2008</year>
<volume>295</volume>
<fpage>C740</fpage>
<lpage>51</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpcell.00333.2007">https://doi.org/10.1152/ajpcell.00333.2007</ext-link>
</comment>
<pub-id pub-id-type="pmid">18596209</pub-id>
</element-citation>
</ref>
<ref id="R242">
<label>242</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamasaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miyashita</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Migita</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Origuchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Eguchi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Cytokines regulate fibroblast-like synovial cell differentiation to adipocyte-like cells</article-title>
<source/>Rheumatology (Oxford)
          <year>2004</year>
<volume>43</volume>
<fpage>448</fpage>
<lpage>52</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/rheumatology/keh092">https://doi.org/10.1093/rheumatology/keh092</ext-link>
</comment>
<pub-id pub-id-type="pmid">14734788</pub-id>
</element-citation>
</ref>
<ref id="R243">
<label>243</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kudo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wakabayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tsutsumi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakakibara</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Hamakubo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aburatani</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2009</year>
<volume>106</volume>
<fpage>5819</fpage>
<lpage>24</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0901676106">https://doi.org/10.1073/pnas.0901676106</ext-link>
</comment>
<pub-id pub-id-type="pmid">19307559</pub-id>
</element-citation>
</ref>
<ref id="R244">
<label>244</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ajuwon</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Spurlock</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes</article-title>
<source/>Am J Physiol Regul Integr Comp Physiol
          <year>2005</year>
<volume>288</volume>
<fpage>R1220</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpregu.00397.2004">https://doi.org/10.1152/ajpregu.00397.2004</ext-link>
</comment>
<pub-id pub-id-type="pmid">15604306</pub-id>
</element-citation>
</ref>
<ref id="R245">
<label>245</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Sargent</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Komura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>QQ</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Whitfield</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Feghali-Bostwick</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<fpage>e13778</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0013778">https://doi.org/10.1371/journal.pone.0013778</ext-link>
</comment>
<pub-id pub-id-type="pmid">21072170</pub-id>
</element-citation>
</ref>
<ref id="R246">
<label>246</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Culver</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Barna</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Raychaudhuri</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bonfield</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Malur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Farver</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Kavuru</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Thomassen</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis</article-title>
<source/>Am J Respir Cell Mol Biol
          <year>2004</year>
<volume>30</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1165/rcmb.2003-0304RC">https://doi.org/10.1165/rcmb.2003-0304RC</ext-link>
</comment>
<pub-id pub-id-type="pmid">14512375</pub-id>
</element-citation>
</ref>
<ref id="R247">
<label>247</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schrum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rippe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Motomura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Anania</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Willson</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Tsukamoto</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptors and hepatic stellate cell activation</article-title>
<source/>J Biol Chem
          <year>2000</year>
<volume>275</volume>
<fpage>35715</fpage>
<lpage>22</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M006577200">https://doi.org/10.1074/jbc.M006577200</ext-link>
</comment>
<pub-id pub-id-type="pmid">10969082</pub-id>
</element-citation>
</ref>
<ref id="R248">
<label>248</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fornoni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elliot</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Breyer</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Striker</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Striker</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation</article-title>
<source/>Am J Physiol Renal Physiol
          <year>2002</year>
<volume>282</volume>
<fpage>F639</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajprenal.00189.2001">https://doi.org/10.1152/ajprenal.00189.2001</ext-link>
</comment>
<pub-id pub-id-type="pmid">11880325</pub-id>
</element-citation>
</ref>
<ref id="R249">
<label>249</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karnik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tekeste</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>McCormick</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Gilliam</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Mirmirani</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia</article-title>
<source/>J Invest Dermatol
          <year>2009</year>
<volume>129</volume>
<fpage>1243</fpage>
<lpage>57</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jid.2008.369">https://doi.org/10.1038/jid.2008.369</ext-link>
</comment>
<pub-id pub-id-type="pmid">19052558</pub-id>
</element-citation>
</ref>
<ref id="R250">
<label>250</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dantas</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>de Melo Rego</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>da Rocha</surname>
<given-names>LF</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>da Rocha Pitta</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lopes Marques</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Branco Pinto Duarte</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Galdino da Rocha Pitta</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The role of PPAR gamma in systemic sclerosis</article-title>
<source/>PPAR Res
          <year>2015</year>
<volume>2015</volume>
<fpage>124624</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2015/124624">https://doi.org/10.1155/2015/124624</ext-link>
</comment>
<pub-id pub-id-type="pmid">26064084</pub-id>
</element-citation>
</ref>
<ref id="R251">
<label>251</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma</article-title>
<source/>Biochem Biophys Res Commun
          <year>2008</year>
<volume>374</volume>
<fpage>231</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2008.07.014">https://doi.org/10.1016/j.bbrc.2008.07.014</ext-link>
</comment>
<pub-id pub-id-type="pmid">18627765</pub-id>
</element-citation>
</ref>
<ref id="R252">
<label>252</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapoor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McCann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Denton</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Leask</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis</article-title>
<source/>Arthritis Rheum
          <year>2009</year>
<volume>60</volume>
<fpage>2822</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.24761">https://doi.org/10.1002/art.24761</ext-link>
</comment>
<pub-id pub-id-type="pmid">19714649</pub-id>
</element-citation>
</ref>
<ref id="R253">
<label>253</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lakos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma</article-title>
<source/>Arthritis Rheum
          <year>2004</year>
<volume>50</volume>
<fpage>1305</fpage>
<lpage>18</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.20104">https://doi.org/10.1002/art.20104</ext-link>
</comment>
<pub-id pub-id-type="pmid">15077315</pub-id>
</element-citation>
</ref>
<ref id="R254">
<label>254</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator</article-title>
<source/>FASEB J
          <year>2009</year>
<volume>23</volume>
<fpage>2968</fpage>
<lpage>77</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.08-128736">https://doi.org/10.1096/fj.08-128736</ext-link>
</comment>
<pub-id pub-id-type="pmid">19395477</pub-id>
</element-citation>
</ref>
<ref id="R255">
<label>255</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carns</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hinchcliff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Whitfield</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Sodin-Semrl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?</article-title>
<source/>Arthritis Res Ther
          <year>2012</year>
<volume>14</volume>
<fpage>R102</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/ar3827">https://doi.org/10.1186/ar3827</ext-link>
</comment>
<pub-id pub-id-type="pmid">22548780</pub-id>
</element-citation>
</ref>
<ref id="R256">
<label>256</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>TGFβ1 controls PPARγ expression, transcriptional potential, and activity, in part, through Smad3 signaling in murine lung fibroblasts</article-title>
<source/>PPAR Res
          <year>2012</year>
<volume>2012</volume>
<fpage>375876</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2012/375876">https://doi.org/10.1155/2012/375876</ext-link>
</comment>
<pub-id pub-id-type="pmid">22997505</pub-id>
</element-citation>
</ref>
<ref id="R257">
<label>257</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Komura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tomcik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Doniparthi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tamaki</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hinchcliff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Distler</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses</article-title>
<source/>Ann Rheum Dis
          <year>2014</year>
<volume>73</volume>
<fpage>446</fpage>
<lpage>54</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/annrheumdis-2012-202716">https://doi.org/10.1136/annrheumdis-2012-202716</ext-link>
</comment>
<pub-id pub-id-type="pmid">23515440</pub-id>
</element-citation>
</ref>
<ref id="R258">
<label>258</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Daugherty</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Thatcher</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Lakatos</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Redonnet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Phipps</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Sime</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2005</year>
<volume>288</volume>
<fpage>L1146</fpage>
<lpage>53</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajplung.00383.2004">https://doi.org/10.1152/ajplung.00383.2004</ext-link>
</comment>
<pub-id pub-id-type="pmid">15734787</pub-id>
</element-citation>
</ref>
<ref id="R259">
<label>259</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marra</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Efsen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Romanelli</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Caligiuri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pastacaldi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Batignani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bonacchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Caporale</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Laffi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pinzani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gentilini</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells</article-title>
<source/>Gastroenterology
          <year>2000</year>
<volume>119</volume>
<fpage>466</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="pmid">10930382</pub-id>
</element-citation>
</ref>
<ref id="R260">
<label>260</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genovese</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cuzzocrea</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Di Paola</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mastruzzo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Catalano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sortino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crimi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Caputi</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Thiemermann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vancheri</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury</article-title>
<source/>Eur Respir J
          <year>2005</year>
<volume>25</volume>
<fpage>225</fpage>
<lpage>34</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.05.00049704">https://doi.org/10.1183/09031936.05.00049704</ext-link>
</comment>
<pub-id pub-id-type="pmid">15684285</pub-id>
</element-citation>
</ref>
<ref id="R261">
<label>261</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iglarz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Touyz</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Viel</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Paradis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Amiri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Diep</surname>
<given-names>QN</given-names>
</name>
<name>
<surname>Schiffrin</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension</article-title>
<source/>Hypertension
          <year>2003</year>
<volume>42</volume>
<fpage>737</fpage>
<lpage>43</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.HYP.0000083511.91817.B1">https://doi.org/10.1161/01.HYP.0000083511.91817.B1</ext-link>
</comment>
<pub-id pub-id-type="pmid">12860836</pub-id>
</element-citation>
</ref>
<ref id="R262">
<label>262</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maejima</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Haraguchi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Onai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kosuge</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Isobe</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma</article-title>
<source/>Lab Invest
          <year>2011</year>
<volume>91</volume>
<fpage>932</fpage>
<lpage>44</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/labinvest.2011.45">https://doi.org/10.1038/labinvest.2011.45</ext-link>
</comment>
<pub-id pub-id-type="pmid">21403641</pub-id>
</element-citation>
</ref>
<ref id="R263">
<label>263</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maeno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aoyagi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sando</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kurabayashi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis</article-title>
<source/>Respir Int Rev Thorac Dis
          <year>2009</year>
<volume>77</volume>
<fpage>311</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000168676">https://doi.org/10.1159/000168676</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R264">
<label>264</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milam</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Keshamouni</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gangireddy</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Hogaboam</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Standiford</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Thannickal</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2008</year>
<volume>294</volume>
<fpage>L891</fpage>
<lpage>901</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajplung.00333.2007">https://doi.org/10.1152/ajplung.00333.2007</ext-link>
</comment>
<pub-id pub-id-type="pmid">18162602</pub-id>
</element-citation>
</ref>
<ref id="R265">
<label>265</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawaguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sakaida</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Omori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Takami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okita</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet</article-title>
<source/>Biochem Biophys Res Commun
          <year>2004</year>
<volume>315</volume>
<fpage>187</fpage>
<lpage>95</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2004.01.038">https://doi.org/10.1016/j.bbrc.2004.01.038</ext-link>
</comment>
<pub-id pub-id-type="pmid">15013444</pub-id>
</element-citation>
</ref>
<ref id="R266">
<label>266</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ido</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hasuike</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kusumoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Numata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsubouchi</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet</article-title>
<source/>Hepatol Res
          <year>2005</year>
<volume>32</volume>
<fpage>235</fpage>
<lpage>42</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hepres.2005.05.008">https://doi.org/10.1016/j.hepres.2005.05.008</ext-link>
</comment>
<pub-id pub-id-type="pmid">16085455</pub-id>
</element-citation>
</ref>
<ref id="R267">
<label>267</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calkin</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Giunti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jandeleit-Dahm</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse</article-title>
<source/>Nephrol Dial Transplant
          <year>2006</year>
<volume>21</volume>
<fpage>2399</fpage>
<lpage>405</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ndt/gfl212">https://doi.org/10.1093/ndt/gfl212</ext-link>
</comment>
<pub-id pub-id-type="pmid">16720596</pub-id>
</element-citation>
</ref>
<ref id="R268">
<label>268</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiss</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Popovic</surname>
<given-names>ZV</given-names>
</name>
<name>
<surname>Bedke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bonrouhi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Babelova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Edenhofer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zschiedrich</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Domhan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abdollahi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schäfer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gretz</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage</article-title>
<source/>Am J Pathol
          <year>2010</year>
<volume>176</volume>
<fpage>2150</fpage>
<lpage>62</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2010.090370">https://doi.org/10.2353/ajpath.2010.090370</ext-link>
</comment>
<pub-id pub-id-type="pmid">20363918</pub-id>
</element-citation>
</ref>
<ref id="R269">
<label>269</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kippenberger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loitsch</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Grundmann-Kollmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Hardt-Weinelt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bernd</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation</article-title>
<source/>J Invest Dermatol
          <year>2001</year>
<volume>117</volume>
<fpage>1430</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1046/j.0022-202x.2001.01537.x">https://doi.org/10.1046/j.0022-202x.2001.01537.x</ext-link>
</comment>
<pub-id pub-id-type="pmid">11886504</pub-id>
</element-citation>
</ref>
<ref id="R270">
<label>270</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grémy</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Benderitter</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist</article-title>
<source/>J Pharmacol Exp Ther
          <year>2008</year>
<volume>324</volume>
<fpage>911</fpage>
<lpage>20</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/jpet.107.129122">https://doi.org/10.1124/jpet.107.129122</ext-link>
</comment>
<pub-id pub-id-type="pmid">18077625</pub-id>
</element-citation>
</ref>
<ref id="R271">
<label>271</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robbins</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Chronic oxidative stress and radiation-induced late normal tissue injury: a review</article-title>
<source/>Int J Radiat Biol
          <year>2004</year>
<volume>80</volume>
<fpage>251</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/09553000410001692726">https://doi.org/10.1080/09553000410001692726</ext-link>
</comment>
<pub-id pub-id-type="pmid">15204702</pub-id>
</element-citation>
</ref>
<ref id="R272">
<label>272</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spitz</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Azzam</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Gius</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology</article-title>
<source/>Cancer Metastasis Rev
          <year>2004</year>
<volume>23</volume>
<fpage>311</fpage>
<lpage>22</lpage>
<comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1023/B">https://doi.org/10.1023/B</ext-link>: CANC.0000031769.14728.bc</comment>
<pub-id pub-id-type="pmid">15197331</pub-id>
</element-citation>
</ref>
<ref id="R273">
<label>273</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Payne</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tommasi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Diz</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Administration of the peroxisomal proliferator-activated receptor gamma agonist pioglitazone during fractionated brain irradiation prevents radiation-induced cognitive impairment</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2007</year>
<volume>67</volume>
<fpage>6</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2006.09.036">https://doi.org/10.1016/j.ijrobp.2006.09.036</ext-link>
</comment>
<pub-id pub-id-type="pmid">17189061</pub-id>
</element-citation>
</ref>
<ref id="R274">
<label>274</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramanan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kooshki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways</article-title>
<source/>Free Radic Biol Med
          <year>2008</year>
<volume>45</volume>
<fpage>1695</fpage>
<lpage>704</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2008.09.002">https://doi.org/10.1016/j.freeradbiomed.2008.09.002</ext-link>
</comment>
<pub-id pub-id-type="pmid">18852043</pub-id>
</element-citation>
</ref>
<ref id="R275">
<label>275</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crosby</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nowling</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Svenson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Nicol</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Gilkeson</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Inflammatory modulation of PPAR gamma expression and activity</article-title>
<source/>Clin Immunol
          <year>2006</year>
<volume>118</volume>
<fpage>276</fpage>
<lpage>83</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clim.2005.09.018">https://doi.org/10.1016/j.clim.2005.09.018</ext-link>
</comment>
<pub-id pub-id-type="pmid">16303334</pub-id>
</element-citation>
</ref>
<ref id="R276">
<label>276</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells</article-title>
<source/>Int J Radiat Oncol Biol Phys
          <year>2013</year>
<volume>85</volume>
<fpage>e239</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijrobp.2012.11.040">https://doi.org/10.1016/j.ijrobp.2012.11.040</ext-link>
</comment>
<pub-id pub-id-type="pmid">23332223</pub-id>
</element-citation>
</ref>
<ref id="R277">
<label>277</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zand</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rahimipour</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salimi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shafiee</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Docosahexaenoic acid sensitizes Ramos cells to gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression</article-title>
<source/>Mol Cell Biochem
          <year>2008</year>
<volume>317</volume>
<fpage>113</fpage>
<lpage>20</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11010-008-9838-x">https://doi.org/10.1007/s11010-008-9838-x</ext-link>
</comment>
<pub-id pub-id-type="pmid">18566752</pub-id>
</element-citation>
</ref>
<ref id="R278">
<label>278</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehman</surname>
<given-names>MU</given-names>
</name>
<name>
<surname>Tahir</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Quaiyoom Khan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lateef</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hamiza</surname>
<given-names>OO</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Diosmin protects against trichloroethylene-induced renal injury in Wistar rats: plausible role of p53, Bax and caspases</article-title>
<source/>Br J Nutr
          <year>2013</year>
<volume>110</volume>
<fpage>699</fpage>
<lpage>710</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0007114512005752">https://doi.org/10.1017/S0007114512005752</ext-link>
</comment>
<pub-id pub-id-type="pmid">23402272</pub-id>
</element-citation>
</ref>
<ref id="R279">
<label>279</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2 diabetes and colon cancer</article-title>
<source/>PPAR Res
          <year>2017</year>
<volume>2017</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2017/5879090">https://doi.org/10.1155/2017/5879090</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R280">
<label>280</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway</article-title>
<source/>Clin Transl Med
          <year>2017</year>
<volume>6</volume>
<fpage>14</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40169-017-0144-7">https://doi.org/10.1186/s40169-017-0144-7</ext-link>
</comment>
<pub-id pub-id-type="pmid">28405929</pub-id>
</element-citation>
</ref>
<ref id="R281">
<label>281</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Opposite interplay between PPAR gamma and canonical Wnt/beta-catenin pathway in amyotrophic lateral sclerosis</article-title>
<source/>Front Neurol
          <year>2016</year>
<volume>7</volume>
<fpage>100</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2016.00100">https://doi.org/10.3389/fneur.2016.00100</ext-link>
</comment>
<pub-id pub-id-type="pmid">27445967</pub-id>
</element-citation>
</ref>
<ref id="R282">
<label>282</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Thermodynamics in gliomas: interactions between the canonical WNT/beta-catenin pathway and PPAR gamma</article-title>
<source/>Front Physiol
          <year>2017</year>
<volume>8</volume>
<fpage>352</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2017.00352">https://doi.org/10.3389/fphys.2017.00352</ext-link>
</comment>
<pub-id pub-id-type="pmid">28620312</pub-id>
</element-citation>
</ref>
<ref id="R283">
<label>283</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Aerobic glycolysis hypothesis through WNT/beta-catenin pathway in exudative age-related macular degeneration</article-title>
<source/>J Mol Neurosci
          <year>2017</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12031-017-0947-4">https://doi.org/10.1007/s12031-017-0947-4</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R284">
<label>284</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Alzheimer disease: crosstalk between the canonical Wnt/beta-catenin pathway and PPARs alpha and gamma</article-title>
<source/>Front Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>459</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2016.00459">https://doi.org/10.3389/fnins.2016.00459</ext-link>
</comment>
<pub-id pub-id-type="pmid">27807401</pub-id>
</element-citation>
</ref>
<ref id="R285">
<label>285</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pradeep</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<fpage>35583</fpage>
<lpage>94</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M403143200">https://doi.org/10.1074/jbc.M403143200</ext-link>
</comment>
<pub-id pub-id-type="pmid">15190077</pub-id>
</element-citation>
</ref>
<ref id="R286">
<label>286</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin</article-title>
<source/>Mol Cell Biol
          <year>2006</year>
<volume>26</volume>
<fpage>5827</fpage>
<lpage>37</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.00441-06">https://doi.org/10.1128/MCB.00441-06</ext-link>
</comment>
<pub-id pub-id-type="pmid">16847334</pub-id>
</element-citation>
</ref>
<ref id="R287">
<label>287</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takada</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kouzmenko</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis</article-title>
<source/>Nat Rev Rheumatol
          <year>2009</year>
<volume>5</volume>
<fpage>442</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrrheum.2009.137">https://doi.org/10.1038/nrrheum.2009.137</ext-link>
</comment>
<pub-id pub-id-type="pmid">19581903</pub-id>
</element-citation>
</ref>
<ref id="R288">
<label>288</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Repression of beta-catenin signaling by PPAR gamma ligands</article-title>
<source/>Eur J Pharmacol
          <year>2010</year>
<volume>636</volume>
<fpage>198</fpage>
<lpage>202</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejphar.2010.03.010">https://doi.org/10.1016/j.ejphar.2010.03.010</ext-link>
</comment>
<pub-id pub-id-type="pmid">20303941</pub-id>
</element-citation>
</ref>
<ref id="R289">
<label>289</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moldes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis</article-title>
<source/>Biochem J
          <year>2003</year>
<volume>376</volume>
<fpage>607</fpage>
<lpage>13</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1042/BJ20030426">https://doi.org/10.1042/BJ20030426</ext-link>
</comment>
<pub-id pub-id-type="pmid">12954078</pub-id>
</element-citation>
</ref>
<ref id="R290">
<label>290</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farshbaf</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ghaedi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shirani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nasr-Esfahani</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator activated receptor gamma (PPARγ) as a therapeutic target for improvement of cognitive performance in Fragile-X</article-title>
<source/>Med Hypotheses
          <year>2014</year>
<volume>82</volume>
<fpage>291</fpage>
<lpage>4</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mehy.2013.12.012">https://doi.org/10.1016/j.mehy.2013.12.012</ext-link>
</comment>
<pub-id pub-id-type="pmid">24456944</pub-id>
</element-citation>
</ref>
<ref id="R291">
<label>291</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation</article-title>
<source/>Curr Stem Cell Res Ther
          <year>2016</year>
<volume>11</volume>
<fpage>247</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">26201865</pub-id>
</element-citation>
</ref>
<ref id="R292">
<label>292</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drygiannakis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Valatas</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sfakianaki</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bourikas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Manousou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kambas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ritis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kolios</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kouroumalis</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis</article-title>
<source/>J Crohns Colitis
          <year>2013</year>
<volume>7</volume>
<fpage>286</fpage>
<lpage>300</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.crohns.2012.04.008">https://doi.org/10.1016/j.crohns.2012.04.008</ext-link>
</comment>
<pub-id pub-id-type="pmid">22578910</pub-id>
</element-citation>
</ref>
<ref id="R293">
<label>293</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farmer</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Regulation of PPARgamma activity during adipogenesis</article-title>
<source/>Int J Obes (Lond)
          <year>2005</year>
<volume>29</volume>
<fpage>S13</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.ijo.0802907">https://doi.org/10.1038/sj.ijo.0802907</ext-link>
</comment>
<pub-id pub-id-type="pmid">15711576</pub-id>
</element-citation>
</ref>
<ref id="R294">
<label>294</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>KI</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Woeller</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Phipps</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Sime</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hindman</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Huxlin</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation</article-title>
<source/>Am J Pathol
          <year>2014</year>
<volume>184</volume>
<fpage>1429</fpage>
<lpage>45</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajpath.2014.01.026">https://doi.org/10.1016/j.ajpath.2014.01.026</ext-link>
</comment>
<pub-id pub-id-type="pmid">24650561</pub-id>
</element-citation>
</ref>
<ref id="R295">
<label>295</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mundra</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mahato</surname>
<given-names>RI</given-names>
</name>
</person-group>
<article-title>Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis</article-title>
<source/>Pharm Res
          <year>2014</year>
<volume>31</volume>
<fpage>1158</fpage>
<lpage>69</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11095-013-1239-5">https://doi.org/10.1007/s11095-013-1239-5</ext-link>
</comment>
<pub-id pub-id-type="pmid">24249038</pub-id>
</element-citation>
</ref>
<ref id="R296">
<label>296</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>Transcription factor Snail is a novel regulator of adipocyte differentiation via inhibiting the expression of peroxisome proliferator-activated receptor γ</article-title>
<source/>Cell Mol Life Sci
          <year>2013</year>
<volume>70</volume>
<fpage>3959</fpage>
<lpage>71</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00018-013-1363-8">https://doi.org/10.1007/s00018-013-1363-8</ext-link>
</comment>
<pub-id pub-id-type="pmid">23689589</pub-id>
</element-citation>
</ref>
<ref id="R297">
<label>297</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells</article-title>
<source/>Nanotechnology
          <year>2012</year>
<volume>23</volume>
<fpage>265101</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1088/0957-4484/23/26/265101">https://doi.org/10.1088/0957-4484/23/26/265101</ext-link>
</comment>
<pub-id pub-id-type="pmid">22700686</pub-id>
</element-citation>
</ref>
<ref id="R298">
<label>298</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<fpage>45020</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M407050200">https://doi.org/10.1074/jbc.M407050200</ext-link>
</comment>
<pub-id pub-id-type="pmid">15308623</pub-id>
</element-citation>
</ref>
<ref id="R299">
<label>299</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells</article-title>
<source/>Pharmacol Res
          <year>2012</year>
<volume>66</volume>
<fpage>219</fpage>
<lpage>25</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.phrs.2012.06.003">https://doi.org/10.1016/j.phrs.2012.06.003</ext-link>
</comment>
<pub-id pub-id-type="pmid">22706027</pub-id>
</element-citation>
</ref>
<ref id="R300">
<label>300</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segel</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Izbicki</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Or</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Wallach-Dayan</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2003</year>
<volume>285</volume>
<fpage>L1255</fpage>
<lpage>62</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajplung.00303.2002">https://doi.org/10.1152/ajplung.00303.2002</ext-link>
</comment>
<pub-id pub-id-type="pmid">12857673</pub-id>
</element-citation>
</ref>
<ref id="R301">
<label>301</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shim</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Combination of a peroxisome proliferator-activated receptor-gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats</article-title>
<source/>J Diabetes Investig
          <year>2014</year>
<volume>5</volume>
<fpage>362</fpage>
<lpage>71</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jdi.12153">https://doi.org/10.1111/jdi.12153</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R302">
<label>302</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabatino</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pancione</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Votino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Colangelo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lupo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Novellino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lavecchia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colantuoni</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer</article-title>
<source/>World J Gastroenterol
          <year>2014</year>
<volume>20</volume>
<fpage>7137</fpage>
<lpage>51</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3748/wjg.v20.i23.7137">https://doi.org/10.3748/wjg.v20.i23.7137</ext-link>
</comment>
<pub-id pub-id-type="pmid">24966585</pub-id>
</element-citation>
</ref>
<ref id="R303">
<label>303</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akinyeke</surname>
<given-names>TO</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>LV</given-names>
</name>
</person-group>
<article-title>Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism</article-title>
<source/>Cancer Biol Ther
          <year>2011</year>
<volume>11</volume>
<fpage>1046</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">21525782</pub-id>
</element-citation>
</ref>
<ref id="R304">
<label>304</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Gregorio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sferra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Speca</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vetuschi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dubuquoy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Desreumaux</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pompili</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cristiano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gaudio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Flati</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Latella</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<fpage>e0171093</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0171093">https://doi.org/10.1371/journal.pone.0171093</ext-link>
</comment>
<pub-id pub-id-type="pmid">28207769</pub-id>
</element-citation>
</ref>
<ref id="R305">
<label>305</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gustafson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Eliasson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis</article-title>
<source/>Diabetologia
          <year>2010</year>
<volume>53</volume>
<fpage>536</fpage>
<lpage>40</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00125-009-1615-1">https://doi.org/10.1007/s00125-009-1615-1</ext-link>
</comment>
<pub-id pub-id-type="pmid">19943155</pub-id>
</element-citation>
</ref>
<ref id="R306">
<label>306</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prusty</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes</article-title>
<source/>J Biol Chem
          <year>2002</year>
<volume>277</volume>
<fpage>46226</fpage>
<lpage>32</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M207776200">https://doi.org/10.1074/jbc.M207776200</ext-link>
</comment>
<pub-id pub-id-type="pmid">12270934</pub-id>
</element-citation>
</ref>
<ref id="R307">
<label>307</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation</article-title>
<source/>Biochem Biophys Res Commun
          <year>2010</year>
<volume>399</volume>
<fpage>55</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2010.07.038">https://doi.org/10.1016/j.bbrc.2010.07.038</ext-link>
</comment>
<pub-id pub-id-type="pmid">20638365</pub-id>
</element-citation>
</ref>
<ref id="R308">
<label>308</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>XD</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>PZ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Hahn-Windgassen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Skeen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sundararajan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2</article-title>
<source/>Genes Dev
          <year>2003</year>
<volume>17</volume>
<fpage>1352</fpage>
<lpage>65</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.1089403">https://doi.org/10.1101/gad.1089403</ext-link>
</comment>
<pub-id pub-id-type="pmid">12782654</pub-id>
</element-citation>
</ref>
<ref id="R309">
<label>309</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Düvel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boback</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Squillace</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>BD</given-names>
</name>
</person-group>
<article-title>Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<fpage>e6189</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0006189">https://doi.org/10.1371/journal.pone.0006189</ext-link>
</comment>
<pub-id pub-id-type="pmid">19593385</pub-id>
</element-citation>
</ref>
<ref id="R310">
<label>310</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimes</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling</article-title>
<source/>Prog Neurobiol
          <year>2001</year>
<volume>65</volume>
<fpage>391</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="pmid">11527574</pub-id>
</element-citation>
</ref>
<ref id="R311">
<label>311</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huelsken</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Behrens</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The Wnt signalling pathway</article-title>
<source/>J Cell Sci
          <year>2002</year>
<volume>115</volume>
<fpage>3977</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">12356903</pub-id>
</element-citation>
</ref>
<ref id="R312">
<label>312</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Coprinus comatus cap inhibits adipocyte differentiation via regulation of PPARγ and Akt signaling pathway</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e105809</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0105809">https://doi.org/10.1371/journal.pone.0105809</ext-link>
</comment>
<pub-id pub-id-type="pmid">25181477</pub-id>
</element-citation>
</ref>
<ref id="R313">
<label>313</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aljada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Mousa</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis</article-title>
<source/>Angiogenesis
          <year>2008</year>
<volume>11</volume>
<fpage>361</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10456-008-9118-0">https://doi.org/10.1007/s10456-008-9118-0</ext-link>
</comment>
<pub-id pub-id-type="pmid">18810647</pub-id>
</element-citation>
</ref>
<ref id="R314">
<label>314</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goetze</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eilers</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bungenstock</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kintscher</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Stawowy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Blaschke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Graf</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Fleck</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gräfe</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>PPAR activators inhibit endothelial cell migration by targeting Akt</article-title>
<source/>Biochem Biophys Res Commun
          <year>2002</year>
<volume>293</volume>
<fpage>1431</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0006-291X(02)00385-6">https://doi.org/10.1016/S0006-291X(02)00385-6</ext-link>
</comment>
<pub-id pub-id-type="pmid">12054675</pub-id>
</element-citation>
</ref>
<ref id="R315">
<label>315</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>ZG</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>YP</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>QZ</given-names>
</name>
</person-group>
<article-title>Piperine attenuates pathological cardiac fibrosis via PPAR-γ/AKT pathways</article-title>
<source/>EBioMedicine
          <year>2017</year>
<volume>18</volume>
<fpage>179</fpage>
<lpage>87</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ebiom.2017.03.021">https://doi.org/10.1016/j.ebiom.2017.03.021</ext-link>
</comment>
<pub-id pub-id-type="pmid">28330809</pub-id>
</element-citation>
</ref>
<ref id="R316">
<label>316</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2007</year>
<volume>292</volume>
<fpage>G113</fpage>
<lpage>23</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpgi.00200.2006">https://doi.org/10.1152/ajpgi.00200.2006</ext-link>
</comment>
<pub-id pub-id-type="pmid">16959952</pub-id>
</element-citation>
</ref>
<ref id="R317">
<label>317</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Melichian</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Warner-Blankenship</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma</article-title>
<source/>Am J Pathol
          <year>2009</year>
<volume>174</volume>
<fpage>519</fpage>
<lpage>33</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2009.080574">https://doi.org/10.2353/ajpath.2009.080574</ext-link>
</comment>
<pub-id pub-id-type="pmid">19147827</pub-id>
</element-citation>
</ref>
<ref id="R318">
<label>318</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>RQ</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>SX</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice</article-title>
<source/>Scand J Gastroenterol
          <year>2009</year>
<volume>44</volume>
<fpage>358</fpage>
<lpage>65</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/00365520802530861">https://doi.org/10.1080/00365520802530861</ext-link>
</comment>
<pub-id pub-id-type="pmid">18991162</pub-id>
</element-citation>
</ref>
<ref id="R319">
<label>319</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stimpson</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Diehl</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells</article-title>
<source/>Biochem Biophys Res Commun
          <year>2006</year>
<volume>350</volume>
<fpage>385</fpage>
<lpage>91</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2006.09.069">https://doi.org/10.1016/j.bbrc.2006.09.069</ext-link>
</comment>
<pub-id pub-id-type="pmid">17010940</pub-id>
</element-citation>
</ref>
<ref id="R320">
<label>320</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Spataro</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists</article-title>
<source/>J Am Soc Nephrol
          <year>2006</year>
<volume>17</volume>
<fpage>54</fpage>
<lpage>65</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1681/ASN.2005030257">https://doi.org/10.1681/ASN.2005030257</ext-link>
</comment>
<pub-id pub-id-type="pmid">16291834</pub-id>
</element-citation>
</ref>
<ref id="R321">
<label>321</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma</article-title>
<source/>Immunol Lett
          <year>2014</year>
<volume>157</volume>
<fpage>9</fpage>
<lpage>15</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.imlet.2013.11.004">https://doi.org/10.1016/j.imlet.2013.11.004</ext-link>
</comment>
<pub-id pub-id-type="pmid">24269293</pub-id>
</element-citation>
</ref>
<ref id="R322">
<label>322</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Backer</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Elinck</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Priem</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leybaert</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor gamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes</article-title>
<source/>J Pharmacol Exp Ther
          <year>2009</year>
<volume>331</volume>
<fpage>496</fpage>
<lpage>503</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/jpet.109.155135">https://doi.org/10.1124/jpet.109.155135</ext-link>
</comment>
<pub-id pub-id-type="pmid">19657050</pub-id>
</element-citation>
</ref>
<ref id="R323">
<label>323</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handy</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mells</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Anania</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis</article-title>
<source/>Biochem J
          <year>2011</year>
<volume>440</volume>
<fpage>385</fpage>
<lpage>95</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1042/BJ20102148">https://doi.org/10.1042/BJ20102148</ext-link>
</comment>
<pub-id pub-id-type="pmid">21846328</pub-id>
</element-citation>
</ref>
<ref id="R324">
<label>324</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafiei</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Shetty</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Rockey</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Adiponectin regulation of stellate cell activation via PPARγ-dependent and -independent mechanisms</article-title>
<source/>Am J Pathol
          <year>2011</year>
<volume>178</volume>
<fpage>2690</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajpath.2011.02.035">https://doi.org/10.1016/j.ajpath.2011.02.035</ext-link>
</comment>
<pub-id pub-id-type="pmid">21641391</pub-id>
</element-citation>
</ref>
<ref id="R325">
<label>325</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ayala</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>JQ</given-names>
</name>
<name>
<surname>Stenvinkel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Axelsson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lindholm</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells</article-title>
<source/>Clin Nephrol
          <year>2007</year>
<volume>68</volume>
<fpage>295</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="pmid">18044261</pub-id>
</element-citation>
</ref>
<ref id="R326">
<label>326</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ</article-title>
<source/>Exp Ther Med
          <year>2017</year>
<volume>13</volume>
<fpage>780</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/etm.2017.4033">https://doi.org/10.3892/etm.2017.4033</ext-link>
</comment>
<pub-id pub-id-type="pmid">28352366</pub-id>
</element-citation>
</ref>
<ref id="R327">
<label>327</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reka</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Kurapati</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Narala</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Bommer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Standiford</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Keshamouni</surname>
<given-names>VG</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition</article-title>
<source/>Mol Cancer Ther
          <year>2010</year>
<volume>9</volume>
<fpage>3221</fpage>
<lpage>32</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1535-7163.MCT-10-0570">https://doi.org/10.1158/1535-7163.MCT-10-0570</ext-link>
</comment>
<pub-id pub-id-type="pmid">21159608</pub-id>
</element-citation>
</ref>
<ref id="R328">
<label>328</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dagher</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hutton</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Bourke</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells</article-title>
<source/>Respir Res
          <year>2010</year>
<volume>11</volume>
<fpage>21</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1465-9921-11-21">https://doi.org/10.1186/1465-9921-11-21</ext-link>
</comment>
<pub-id pub-id-type="pmid">20178607</pub-id>
</element-citation>
</ref>
<ref id="R329">
<label>329</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation</article-title>
<source/>Mol Pharmacol
          <year>2006</year>
<volume>70</volume>
<fpage>415</fpage>
<lpage>25</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/mol.106.022954">https://doi.org/10.1124/mol.106.022954</ext-link>
</comment>
<pub-id pub-id-type="pmid">16611854</pub-id>
</element-citation>
</ref>
<ref id="R330">
<label>330</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulkarni</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Thatcher</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Maggirwar</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Phipps</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Sime</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e15909</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0015909">https://doi.org/10.1371/journal.pone.0015909</ext-link>
</comment>
<pub-id pub-id-type="pmid">21253589</pub-id>
</element-citation>
</ref>
<ref id="R331">
<label>331</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bujor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Highland</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hant</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Trojanowska</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels</article-title>
<source/>Arthritis Rheum
          <year>2010</year>
<volume>62</volume>
<fpage>2117</fpage>
<lpage>26</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.27463">https://doi.org/10.1002/art.27463</ext-link>
</comment>
<pub-id pub-id-type="pmid">20309867</pub-id>
</element-citation>
</ref>
<ref id="R332">
<label>332</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwano</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>PTEN as a new agent in the fight against fibrogenesis</article-title>
<source/>Am J Respir Crit Care Med
          <year>2006</year>
<volume>173</volume>
<fpage>5</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1164/rccm.2510001">https://doi.org/10.1164/rccm.2510001</ext-link>
</comment>
<pub-id pub-id-type="pmid">16368792</pub-id>
</element-citation>
</ref>
<ref id="R333">
<label>333</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>XZ</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>NS</given-names>
</name>
</person-group>
<article-title>Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists</article-title>
<source/>Hepatobiliary Pancreat Dis Int
          <year>2012</year>
<volume>11</volume>
<fpage>467</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="pmid">23060391</pub-id>
</element-citation>
</ref>
<ref id="R334">
<label>334</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kattla</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Carew</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Heljic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Godson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brazil</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition <italic>in vitro</italic> and <italic>in vivo</italic></article-title>
<source/>Am J Physiol Renal Physiol
          <year>2008</year>
<volume>295</volume>
<fpage>F215</fpage>
<lpage>25</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajprenal.00548.2007">https://doi.org/10.1152/ajprenal.00548.2007</ext-link>
</comment>
<pub-id pub-id-type="pmid">18495798</pub-id>
</element-citation>
</ref>
<ref id="R335">
<label>335</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krishnaveni</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Ivan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DeMaio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Ehrhardt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Crandall</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Borok</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e38827</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0038827">https://doi.org/10.1371/journal.pone.0038827</ext-link>
</comment>
<pub-id pub-id-type="pmid">22745681</pub-id>
</element-citation>
</ref>
<ref id="R336">
<label>336</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ann</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Flodby</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Krishnaveni</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Liebler</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Minoo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Crandall</surname>
<given-names>ED</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)</article-title>
<source/>J Biol Chem
          <year>2012</year>
<volume>287</volume>
<fpage>7026</fpage>
<lpage>38</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M111.276311">https://doi.org/10.1074/jbc.M111.276311</ext-link>
</comment>
<pub-id pub-id-type="pmid">22241478</pub-id>
</element-citation>
</ref>
<ref id="R337">
<label>337</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenbloom</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Jimenez</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies</article-title>
<source/>Ann Intern Med
          <year>2010</year>
<volume>152</volume>
<fpage>159</fpage>
<lpage>66</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7326/0003-4819-152-3-201002020-00007">https://doi.org/10.7326/0003-4819-152-3-201002020-00007</ext-link>
</comment>
<pub-id pub-id-type="pmid">20124232</pub-id>
</element-citation>
</ref>
<ref id="R338">
<label>338</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis</article-title>
<source/>Curr Opin Rheumatol
          <year>2010</year>
<volume>22</volume>
<fpage>671</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/BOR.0b013e32833de1a7">https://doi.org/10.1097/BOR.0b013e32833de1a7</ext-link>
</comment>
<pub-id pub-id-type="pmid">20693905</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>